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ABSTRACT 
Contamination, Infection and Inflammation Control in an Experimental 
Mucosal Cyst Model Using Athymic Nude Mice 
 
M. Wang 
 
MSc (Dent) thesis, Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, 
University of the Western Cape 
 
Various experimental cyst models have been developed in animals to study the 
epithelial-mesenchymal interactions and the etiology, pathogenesis, growth and 
behaviour of cysts. An artificial cyst model constructed from human vaginal 
mucosa in athymic nude mice has been suggested as an in vivo biotest system to 
study oral mucosal diseases. However, previous investigators have rarely provided 
information on the identification of microbiological contaminants and infection 
control. This study therefore identified the common pathogens and risk factors. 
The effects of Terramycin in drinking water and subcutaneous injections of 
Gentamicin (twice daily) were examined. The silk and nylon sutures were 
randomly used to construct the artificial cysts and stitch the skin wounds of mice.    
 
Forty- three male athymic nude mice (MFI nu nu) were implanted with human 
vaginal mucosal cysts under general anaesthesia with Ketamine [25mg/kg] and 
Medetomidine [0.5mg/kg]. Cysts in 37 mice were recovered after 9 weeks of 
growth. Twenty-three cyst linings had retained the original structure of the vaginal 
epithelium. No marked difference was present between the thickness of 9-week 
old cyst linings and donor vaginal epithelium. The contaminants isolated from the 
skin of mice before implantation were mainly normal commensals of healthy 
experimental animals. Coagulase negative Staphylococci (CNS) were the most 
frequently isolated contaminats (58.1%) from the implanted cyst site after 9 weeks 
of growth, followed by Enterococcus faecalis (22.6%). There was no distinct 
difference in the number of cases with intact cyst formation between the 
Terramycin/ vitamin cocktail group and the control group. The frequency of poor 
wound healing and/or murine epidermis ingrowth was three times higher in 
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animals stitched with silk sutures than in those cases where nylon sutures were 
used. The inflammation around silk sutures was generally more severe than that 
around nylon sutures. A foreign body reaction and acute inflammatory infiltrate 
usually surrounded the silk sutures. The loss of three mice was attributed to the 
high irritation of peracetic acid. 
  
It is concluded that CNS and Enterococci were the most common pathogens found 
in the cyst model. Gentamicin proved to be more efficient against Gram-negative 
contaminants than Terramycin. Poor wound healing and murine epidermis 
ingrowth were the highest risk factors for failure of the implants. Nylon suture is 
an appropriate non-absorbable suture for minimising infection around 
experimental cysts. The prevention of microbiological contamination is 
compromised when the isolators are used in a substandard animal room. High 
irritative disinfectants and substandard animal housing must be avoided. 
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CHAPTER 1: INTRODUCTION 
There is a need for a stable experimental cyst model offering a closed 
environment similar to the oral cavity and which allows for controlled studies on 
the mucosal absorption mechanisms and local reaction patterns to introduced 
agents such as carcinogens, viruses, drugs and vaccines. The experimental cysts 
have to be constructed from fragments of non-keratinised mucosa to simulate 
natural oral conditions. However, the availability of disease-free fresh human 
oral mucosa in dimensions suitable for experimental purposes is very limited.  
 
An implanted cyst model constructed from human vaginal mucosa has been 
established in athymic nude mice by Thompson and co-workers (Thompson et al, 
2001a; b; Thompson, 2002). The cyst linings had retained the structure and 
permeability features of the vaginal epithelium. It has been suggested that this 
cyst model could be used as an in vivo biotest system to study oral diseases, 
because buccal and vaginal epithelia have similar histological characteristics, 
protective functions and permeability characteristics to water and chemical 
substances (Thompson et al, 2001; Van der Bijl et al, 1997; 1998a; b; c; 1999; 
2000).  
 
Because the susceptibility of athymic nude mice to infection is far greater than 
that for normal animals, the implantation sites and cysts in athymic mice have 
often been described to be affected by acute pyogenic infection typically 
occurring 10-14 days following implantation (Holmstrup et al, 1981d; Mackenzie 
et al, 1979). This often leads to death of the animals or unsuccessful identification 
of the transplant tissue. The containment or prevention of infectious disease is 
thus an important issue in the achievement of reliable experimental results. After 
Gentamicin antibiotic cover was introduced and Terramycin added to drinking 
water, the recovery rate of the transplant tissue raised from 47% to 87% 
(Holmstrup et al, 1981a; Mackenzie et al, 1979; Thompson & Van Wyk, 1996; 
Van Wyk & Thompson, 1992).  
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Other causes of infection and failure of the implants due to an inflammatory 
reaction can be attributed to contamination (ingrowth) of the implant site with 
murine cutaneous tissue and tissue reactions to absorbable suture material and 
other contaminants (Mackenzie et al, 1979; Thompson, 2002). 
 
It obviously is mandatory to establish and maintain a strictly clean general 
environment; in particular a sterile working environment for the animals is 
required. During the project, the animals must be housed in isolators to avoid 
direct contact with each other or humans, and all cages and materials used 
including bedding, food and water must be autoclaved or sterilised before use.  
 
The present project was initiated to: 1) identify the common pathogens and factors 
which could adversely affect the establishment and maintenance of this elegant in 
vivo biotest model; 2) test the efficacy of Terramycin added to drinking water and 
subcutaneous injections of Gentamicin (twice daily) in preventing infection of the 
animals and the experimental implantation sites; 3) test if the use of 
non-absorbable suture material around the implant and closing the incision wound 
reduces the inflammatory response and subsequent fibrosis. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Evaluation and application of previous experimental cyst 
models in the oral environment 
 
Cyst models in jawbones. Cysts are more common in the jaws than in any other 
bone because of the many rests of epithelium remaining in the tissues after dental 
development. There are two classes of epithelial-lined cysts of the jaws: one is 
derived from the odontogenic epithelium; and the second is from the 
non-odontogenic epithelium (Soskolne et al, 1976). In a number of studies, cysts 
produced in experimental animals were used to study the pathogenesis of jaw 
cysts. Some of them described the transplantation of tooth germs into soft tissue 
sites (Bartlett et al, 1973; Klein et al, 1971; Riviere & Sabet, 1973), while others 
used epithelium that was implanted into deeper connective tissue (Baker & 
Mitchell, 1965; Epstein & Kligman, 1957). Soskolne et al (1976), Ramanathan 
and Philipsen (1981) have described experimental models in which they 
implanted keratinised epithelium into the mandibles of rats in order to study the 
pathogenesis and growth of jaw cysts, and to determine their ultimate fate.  
 
Cyst models developed from oral mucosa. The structure of normal human oral 
epithelium varies in different anatomical regions with respect to a number of 
characteristics including thickness, pattern of keratinisation, the epithelial 
connective tissue interface and the biochemical properties of the cells (Squire et 
al, 1976). It has been reported that epithelium accidentally implanted during 
surgery or trauma is capable of cyst formation (Abrams et al, 1977; Ettinger & 
Maderson, 1973; Papanayotou & Kayavis, 1977; Thaddeus & Shafter, 1958; 
Torres & Higa, 1970). 
  
There is considerable evidence supporting the role of epithelial-mesenchymal 
interactions in the proliferation and differentiation of these tissues. 
Epithelial-mesenchymal interactions can be studied by tissue dissociation and 
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cross-recombination. In these studies, epithelium is separated from its original 
connective tissue and recombined with connective tissue from a different source 
(Mackenzie, 1984). Mackenzie et al (1979), Holmstrup et al (1981a-d), and 
Vedtofte et al (1982) built an experimental model by transplanting normal and 
leukoplakic human oral mucosa to subdermal sites in athymic mice. They 
demonstrated that the epithelial lining of the cysts retain the normal histological 
features of the human tissue during the growth and differentiation phases; this 
would allow researchers to investigate the role of epithelial-mesenchymal 
interactions in human oral diseases. This model can also be used to evaluate the 
influence of connective tissue on epithelium during chemically induced oral 
mucosal carcinogenesis (Rich & Reade, 2001). 
 
Other models. Lindholm et al (1984) have transplanted buccal mucosa into 
various structures in the neck of Beagle dogs and produced experimental cysts. 
These cysts served as a tissue framework in which they studied the feasibility of 
combining biocompatible materials with mucosal membrane and which could be 
used as substitutes for parts of the larynx or trachea. 
 
However, the availability of fresh human oral mucosa in sizes suitable for 
experimental purposes is limited. For this reason, fresh and/or frozen autopsy 
tissues, or tissue derived from animal models have been used as substitutes for 
fresh specimens of human oral mucosa (Holmstrup et al, 1981a-d; Mackenzie et 
al, 1979; Ramanathan & Philipsen, 1981; Soskolne et al, 1976; Vedtofte et al, 
1982).  
 
Because of the similarity between the histological, electron microscopic and 
permeability features of human vaginal mucosa and buccal mucosa, it has been 
proposed that human vaginal mucosa could be used as a substitute for buccal 
mucosa in in vitro and in vivo experimental studies (Thompson & Van Wyk, 
1996; Thompson et al, 2000, Thompson et al, 2001b; Van Wyk & Thompson, 
1992). These may include permeability and drug-absorption studies of a variety of 
chemical compounds, including carcinogens. 
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2.2 The case for human vaginal mucosa as a substitute of buccal 
mucosa in experimental models 
 
Similarities: Buccal and vaginal epithelia have similar protective functions and 
histological characteristics. The protective functions include those that prevent 
mechanical damage to deeper lying tissues and act as barriers to the entry of 
microorganisms and noxious substances (Thompson et al, 2001a). The 
histological characteristics of the epithelial layers, epithelial thickness, and 
surface keratinisation are similar; the shared ultrastructural characteristics include 
the stacked intercellular lipid lamellae and membrane-bound intracellular granules 
containing internal lamellae, and the lipid compositions of two types of mucosa 
(Thompson et al, 2001a). Additionally no differences were observed in the 
morphology or growth patterns between the vaginal and buccal epithelium in cell 
cultures (Van Eyk & Van der Bijl, 1998). Similar permeability characteristics of 
fresh or frozen vaginal and buccal mucosa to water, 17ββ-estradiol, dextran, 
vasopressin, benzo[a]pyrene, and Sumatriptan have been demonstrated (Van der 
Bijl & Van Eyk, 1999; Van der Bijl et al, 2000; 1997; 1998a-c). 
 
Differences: The glycogen content and the thickness of vaginal and buccal 
epithelium differ. The thickness of vaginal epithelium is influenced by hormonal 
stimulation and varies in particular during the menstrual cycle, pregnancy, post 
partum period, lactation period and in the post-menopausal female. Therefore, 
only vaginal epithelia from post-menopausal women on hormone replacement 
therapy are used in many studies to minimise hormonal influences (Van der Bijl 
& Van Eyk, 1999; Van der Bijl et al, 1997; 1998d; Van Eyk & Van der Bijl, 
1998; Van Wyk & Thompson, 1992). 
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2.3 The methodology and benefits of establishing human vaginal 
mucosa cysts in nude mice as an animal model to study oral 
mucosal properties 
 
Approximately 97% of all animals used in research, for teaching, and substance 
testing are mice or rats. This is because they are small and easily housed and bred, 
short lived, relatively inexpensive and they are genetically very similar to humans 
(FBR, 2003). The nude mouse, a hairless immunodeficient mutant, was 
discovered in 1962 and does not reject tissue or organs transplanted from other 
species. It lacks a thymus, and cannot produce T-lymphocytes which are an 
essential component of the immune system. Since they were discovered, nude 
mice have been widely used to study various aspects of tumour behaviour or in 
tissue transplantation studies. Lack of hair growth allows for visualization of 
subcutaneous transplants and the immunodeficiency state supports growth of 
many types of foreign cells (UCCAA, 2003). Immunodeficient mice have also not 
only been used in microbiological and parasitological experimental studies, but 
also for genetical, nutritional and environmental studies.  
 
An implantation cyst model constructed from human vaginal mucosa has been 
established in athymic nude mice (Thompson & Van Wyk, 1996; Thompson et al, 
2001b). It has been suggested that this cyst could be used as an in vivo biotest 
system to study oral diseases because the cyst lining had retained the structure and 
permeability features of the vaginal epithelium that is similar to oral epithelium. 
Moreover, the epithelial lining of the cyst remains associated with its own 
connective tissue and would thus not be subjected to messages from a foreign 
connective tissue (Thompson et al, 2001b, Van Wyk & Thompson, 1992).  The 
model can thus be used to study the induction of pathological changes in the cyst 
linings, to test biomaterials and to investigate epithelial transformations such as 
hyperplasia and metaplasia. 
 
The containment or prevention of disease is thus an important contribution to 
achieving reliable experimental results. One major problem encountered during 
 
 
 
 
 7
the establishment of this model has been the relative high failure rate of the 
implanted cysts due to inflammation and necrosis. Epithelial ingrowth from the 
surgical wound margins is also a problem (Mackenzie et al, 1979). 
 
2.4 Putative causes of inflammation during the implantation cyst 
experiments 
 
Because the susceptibility of immunodeficient mice to infection with pathogenic 
viruses and saprophytic bacteria is far greater than for normal animals, the 
implantation sites and cysts in athymic mice have often been described to be 
affected by acute pyogenic infection typically occurring 10-14 days following 
implantation (Holmstrup et al, 1981d; Mackenzie et al, 1979). This often leads to 
death of the animal or unsuccessful identification of the transplant tissue.  
 
The literature not only lacks reports on proper peri- and post-operative 
anti-infective care, but also reveals that most of the experimental studies before 
1980’s on skin and oral mucosa implantation cysts have been performed without 
antibiotic cover and no specific measures were taken to prevent infection (Baker 
& Mitchell, 1965; Epstein & Kligman, 1957; Mackenzie et al, 1979). The fact 
that the animals did not receive antibiotic treatment and that the implants were 
rinsed in normal saline, often resulted in massive infection and necrosis of the 
implants. The “hat-shaped” polyethylene capsules, which were introduced by 
Mackenzie et al (1979) to protect oral mucosal implants by preventing contraction 
of the connective tissue bed and the ingrowth of the epidermis from the wound 
margins and surrounding surface only yielded a 44% success rate. Holmstrup et al 
(1981d) frequently noted that infection of the implant sites and loss of the 
capsules was associated with an open skin surface condition; however the 
presence of capsules did not appear to influence the recovery rate of human oral 
mucosa implants. A reduction of the infection rate was obtained by suturing and 
covering the incision wound with Histoacryl® as an antibiotic barrier to 
contamination. The use of Specified Pathogen Free (spf) inbred animals also 
reduced the infection risk. 
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When Terramycin or Gentamicin antibiotic cover was introduced, minimal 
infection was encountered and a higher yield of successful implantation cysts was 
obtained (Van Wyk & Thompson, 1992; Ramanathan & Philipsen, 1981).   
 
However, it is still mandatory to establish and maintain a strictly clean general 
environment and in particular a sterile working environment for the animals. 
Because diseases may be transmitted from animal to animal by direct contact or 
via pathogens shed or excreted via their faeces, urine, saliva, exhaled air or 
dander, the experimental animals must be individually housed in isolators to avoid 
direct contact with each other or humans (Poole, 1987). All cages and materials 
used including bedding, food and water, must be autoclaved for sterilisation 
before use. The use of a laminar air-flow cabinet during the surgical procedure 
affords greater economy of time and effort in keeping the germ-free status of mice 
and no more contamination occurs compared to other methods (Taylor, 1975).  
 
Previous studies have reported an improvement in the recovery rate of the 
transplant tissue from 47% to 87% when these measures were introduced 
(Holmstrup et al, 1981a; b; d; Mackenzie et al, 1979; Thompson & Van Wyk, 
1996; Van Wyk & Thompson, 1992). However it is imperative to strive for an 
even better success rate since animal experiments are expensive and suffering of 
the animals should be kept to a minimum. 
 
Other causes of infection and failure of the implants due to an inflammatory 
reaction can be attributed to contamination (ingrowth) of the implant site with 
murine cutaneous tissue and tissue reactions against absorbable suture material 
and other contaminants (Thompson, 2002). Because of these various features, the 
choice of suture material for any given wound closure should not be made 
arbitrarily, but rather with careful attention to the physical and handling properties 
of the suture, as well as its propensity for eliciting tissue reaction and promoting 
infection (J&J, 2004). For skin, non-absorbable sutures are usually used. 
Non-absorbable sutures are defined by the U.S. Pharmacopeia as "flexible strands 
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of material that are suitably resistant to the action of living mammalian tissue" 
(USPC, 2000). The most commonly used non-absorbable sutures are silk, nylon 
polypropylene, braided polyesters and polybutester (LaMorte, 2002). 
 
Nylon (Ethilon, Dermalon) is the most widely used non-absorbable suture in skin 
surgery. It has high tensile strength, minimal tissue reactivity, excellent elastic 
properties and low cost. The major drawback to nylon is its high degree of 
memory. A greater number of knot throws (three or four) are required to hold a 
given stitch in place. Silk is a naturally occurring proteinaceous filament spun by 
silkworm larvae as they build cocoons. Silk is made into a braided suture, which 
has perhaps the best handling and tying characteristics of any suture material. In 
skin surgery, silk is used around the eyelids and lips, where it can lay flat, causes 
minimal irritation and has a low incidence of infection. (Moy et al, 1991; Lin et 
al, 2005) 
 
Finally, it is highly probable that epithelial ingrowth from the surgical wound 
margins following wound dehiscence could be prevented by reducing the 
mechanical trauma of the stretched skin over an anatomically tight implantation 
site. Traditionally, implants have been subcutaneously inserted in the flank region 
of the experimental animals, however the skin in the neck region of nude mice is 
much looser and lends itself much better for implantation of rigidly supported 
mucosal transplants. (Thompson, 2002)  
 
2.5 Putative microbiological contaminants of transplant models 
 
Viruses.   
The transplant tumours and tissues are the common source of murine viruses. The 
list of viruses includes Lactate DeHydrogenase virus (LDH), Minute Virus of 
Mice (MVM), Mouse Hepatitis Virus (MHV), Lymphocytic ChorioMeningitis 
virus (LCM), Polyoma virus, Reo3 and Sendai virus (Poole, 1987). 
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Bacteria.   
Enterobacter species are rod-shaped bacteria that are found in the environment 
and also in the human intestinal tract.  Some species are pathogenic, the most 
common being E. cloacae and E. aerogenes, which can cause opportunistic 
infections in immunocompromised patients. The urinary and respiratory tracts are 
the most common sites of infection with Enterobacter species. (HPA, 2006a) 
 
Enterococcus species are commonly found in the bowel of normal healthy 
individuals. Entercocci can cause a range of illnesses including urinary tract 
infections, bacteraemia and wound infections. The two most common species are 
E. faecalis and E. faecium (HPA, 2006b). 
 
Klebsiella species are rod shaped-bacteria that are found in the environment and 
also in the human intestinal tract. K. pneumoniae is the most common species 
isolated from hospital patients. A second species, K. oxytoca is an occasional 
cause of wound, bloodstream and urinary tract infections (HPA, 2006c). 
 
Pseudomonas aeruginosa is a Gram-negative bacterium commonly found in soil 
and ground water. It rarely affects healthy people and most community-acquired 
infections are associated with prolonged contact with contaminated water.  P. 
aeruginosa is increasingly important clinically as it is a major cause of both 
healthcare-associated infections and chronic lung infections in people with cystic 
fibrosis (HPA, 2006d).  
 
Staphylococcus spp  
Staphylococci are ubiquitous in the environment. Natural populations are 
associated with skin, skin glands and mucous membranes of warm-blooded 
animals. They have been isolated from animal products such as meat, milk and 
cheese, and other sources such as soil, sand, seawater, fresh water, dust and air. It 
is difficult to get rid of these commensals even by the vigorous routine scrubbing 
protocols that precede surgery. The main obvious effect of infection by 
staphylococci is the production of pus in boils, abscesses and suppurating wounds. 
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Staphylococci also produce toxins of great lethality; one of these toxins can cause 
food poisoning (Dawson, 1989; Pearse, 1997). 
 
In 1884, Rosenbach described the two pigmented colony types of staphylococci 
and proposed the appropriate nomenclature: Staphylococcus aureus (yellow) and 
Staphylococcus albus (white). The latter species is now named Staphylococcus 
epidermidis. Staphylococci can be divided into two groups, depending on whether 
they produce the enzyme coagulase. Nearly all strains of S. aureus are 
coagulase-positive; nearly all strains of S. epidermidis lack this enzyme. S. aureus 
should always be considered a potential pathogen; most strains of S. epidermidis 
are nonpathogenic and may even play a protective role in their host as normal 
flora although they may be a pathogen in the hospital environment (Todar, 2005) 
as they have antibiotic resistance to penicillin. 
 
Because of the involvement in some kinds of human and animal diseases, the 
coagulase-negative staphylococci (CNS) have been studied extensively. CNS 
lives naturally on the skin and mucous membranes of humans and is therefore 
often found in clinical specimens. Only half of the 32 coagulase-negative species 
have been found in specimens of human origin. They can be divided into two 
groups, depending on whether they are resistant or susceptible to novobiocin 
(Albamycin): a) Novobiocin-susceptible: S. epidermidis, S. haemolyticus, S. 
auricularis, S. capitis subsp capitis, S. capitis subsp urealyticus, S. caprae, S 
hominis, S. lugdunensis, S. pasteuri, S. saccharolyticus, S. schleiferi subsp 
schleiferi, S. simulans, S. warneri; b) Novobiocin-resistant: S. saprophyticus 
subsp saprophyticus, S. cohnii subsp cohnii, S. sciuri, and S. xylosus. (Von Eiff et 
al, 2001)   
 
Streptococci spp. 
Streptococci can be found in the majority of the human population, favouring 
colonisation of the throat, nose and mucous membranes of the perineum. They 
can cause a wide variety of diseases. (Dawson, 1989; Pearse, 1997) 
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Fungi    
Superficial fungal infections of the skin are usually caused by dermatophytes, 
fungi which invade only ‘dead’ tissues of the skin or its appendages, such as the 
corneal layer of the skin, the nails, hair, etc. 
 
Candida albicans may be present in the oral cavity under normal circumstances as 
part of the oral flora but will become pathogenic under certain circumstances to 
cause candidiasis, especially in suppressed immune conditions. It can also cause 
inflammation of the vagina (vaginal candidiasis), especially before puberty and 
after menopause, when the acidity of the vaginal fluids is such as to encourage its 
growth (Dawson, 1989; Pearse, 1997). It has long been recognised that fungi can 
be poisonous to man and animals.  
 
Aspergillus flavus for instance produces aflatoxin that is highly carcinogenic in 
experimental animals as well as causing other diseases in animals and fish 
(Dawson, 1989). 
 
 
2.6 General antibiotics, antimicrobials and disinfectants applied 
in animal research 
 
Terramycin (oxytetracycline) is a broad-spectrum antibiotic compound with a 
wide range of activity against both Gram-positive and also to a lesser extend 
Gram-negative bacteria. It also has anti-inflammatory properties. Terramycin had 
a remarkably low toxicity and minimal side effects when taken by animals. 
(Todar, 2002) 
 
Gentamicin is a broad spectrum aminoglycoside antibiotic widely used in 
veterinary medicine for the treatment of serious infections. Gentamicin is 
primarily active against gram-negative bacteria including: Pseudomonas 
aeruginosa, Proteus spp., Escherichia coli, Klebsiella spp., Enterobacter spp., 
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Serratia spp., Actinobacillus equuli, Haemophilus equigenitalis, and many species 
of Salmonella and shigella. Gentamicin is also active against Staphylococcus spp. 
(including penicillin and methicillin-resistant strains) and Rhodococcus equi. (AL, 
2004; Todar, 2002) 
 
Peracetic acid (C2H4O3) (PAA) is a mixture of acetic acid (CH3COOH) and 
hydrogen peroxide (H2O2) in a watery solution. PAA is usually produced in 
concentrations of 5-15%. PAA is caustic topically, but is extremely germicidal 
due to its oxidation action. A special advantage of PAA is it has no harmful 
decomposition products (i.e., acetic acid, water, oxygen, hydrogen peroxide) and 
leaves no residue (OMRI, 2000a, b). PAA is a high-level hospital disinfectant with 
a proven efficacy of the rapid action against all microorganisms. PAA is an 
effective disinfectant on Pseudomonas aeruginosa (Chang, et al, 2005).  
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CHAPTER 3: RESEARCH DESIGN AND 
METHODOLOGY 
3.1  Aims and objectives 
3.1.1 To identify the commensals and contaminant microorganisms of this 
experimental mucosal implantation cyst model in athymic nude 
mice. 
3.1.2 To distinguish the effect of two antibiotics coverage modalities to 
eliminate the risk of infection and failure of this model.  
3.1.3 To evaluate two kinds of sutures: silk and nylon. 
 
 
3.2  Nature of this study 
This study should be considered as a pilot project due to the limited number of 
athymic nude mice used. 
 
 
3.3  Animal husbandry and care 
 
3.3.1 Animal husbandry and description of the isolators: 
Athymic nude mice (MFI nu nu) of male sex were obtained in batches from 
the animal unit of Medical School of the University of the Witwatersrand 
(Wits). The animals were transported by airfreight in sterilised air-filtered 
boxes and upon arrival the mice were transferred and maintained in one of 
three isolators at the animal facilities of the Department of Medical 
Bioscience of the University of the Western Cape.  
 
The polyvinyl chloride (PVC) isolator (Fig. 1) is suitable for small laboratory 
animals. It utilises room space more effectively and is particularly useful 
where accommodation is restricted. There are two ancillary equipments for 
the isolators: 1) an autoclavable stainless steel trolley for the sterility of the 
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food and bedding (Fig 3); 2) the laminar air-flow cabinet for surgical 
procedures (Fig 4). 
 
 
  Figure 1: Isolator 
 
A→ Unidirectional airflow air filter: cotton filter media was used for 
sterilizing the air blowed into the isolators; the sterilized filters were 
changed every 3 weeks.  
 
B→ Unidirectional airflow exhaust liquid filter: contains Glycerol 
[C3H3(OH)3], to prevent the air flow back from outside to inside the 
isolator.  
 
C→ A pair of sealed long sleeve gloves: Neoprene® gloves have sufficient 
chemical resistance to withstand decontaminating agents.  
D→ A sealed Rapid Transfer Port unit allows the transfer of materials into/out 
of the isolator without compromising the sterility of the isolator. This 
procedure is one of the greatest potential sources of contamination. 
 Static Pass-through is the most basic using way: materials are placed 
into the port from outside and sterilised with peracetic acid (see 
Appendix I); the outside cover is closed and the materials are kept in the 
A 
C 
D 
B 
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port for two hours; then the inside cover can be opened and the materials 
passed through to the isolator (Fig 2). The port is sterilised with 
Peracetic Acid for 2 hours when the isolator is joined with the food 
autoclave unit and the laminar air-flow unit (Fig 5 and 6). 
 
 
Figure 2: Materials kept in the port for sterilisation by peracetic acid. 
 
 
 Figure 3: The food autoclave unit, the sterilised food (thin arrow) and 
bedding (thick arrow) inside. 
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  Figure 4: The laminar air-flow unit for implantation procedures. 
 
 
 
Figure 5: The isolator joined with the food autoclave unit by a transfer tunnel. 
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  Figure 6: The isolator joined with the laminar air-flow unit. 
 
3.3.2 Animal care 
Before the implantation, the mice were accommodated in separate cages in 
batches of three on a bedding of autoclaved wood shavings and fed ad-lib 
with sterilised surgery water and autoclaved rodent breeder food. The 
autoclaving of the bedding and food was done in the Microbiology 
laboratory of the Department of Medical Bioscience.  
 
After the implantation procedure, each animal was separately 
accommodated on a bedding of autoclaved wood shavings and fed ad-lib 
with normal sterilised surgery water or Terramycin/vitamin cocktail (see 
Appendix II) and autoclaved rodent breeder food for 9 weeks. The water and 
the cocktail supplies were refreshed every 2 days as to avoid contamination 
with fungi and protozoa. 
 
The animals’ health condition was closely observed and a short note was 
recorded every day. (See Appendix III) 
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The floor and the walls of the animal house were washed at regular weekly 
intervals with Biocide® (3g/l); the isolators were sterilised daily and the 
working surfaces and instruments were sterilised at all times with 1% 
potassium peroxsulphate solution (Virkon® 1g/l).  
 
The temperature of the animal room was kept at 26 degrees Celsius and the 
light cycle was set for alternating 12 hours of light and 12 hours of darkness. 
 
3.4  Antibiotic cover of the experimental mice 
 
 
Immediately after implantation, all mice were administered with 2.000 units 
of Penicillin-G intramuscular. The mice were randomly allocated to three 
experimental groups and one control group as described below: ultimately 
there were 10 animals in each group.  
 
Groups 1 and 2 were given an antibiotic (Terramycin)/vitamin cocktail in 
drinking water. 
Groups 3 and the Control Group were given normal sterilised water. 
Group 1 and 3 were administered subcutaneously with Gentamicin (1mg/100 
bodyweight) twice daily for a postoperative period of 14 days. 
 
Table 1: Experimental groups 
Group 1: 10 mice 
Antibiotic (Terramycin)/vitamin 
cocktail. 
Gentamicin (I.M. b.d.) x14 days  
Group 2: 10 mice 
Antibiotic (Terramycin)/vitamin 
cocktail 
Group 3: 10 mice 
Gentamicin (I.M. b.d.) x14 days 
 
Control Group: 10 mice 
No postoperative antibiotics 
except 1 penicillin injection 
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The body weight was as an important parameter of the health condition of all 
the experimental animals. Every animal was weighed before the operation, 
after 14 days of injections in case of Gentamicin injections (Groups 1 and 3), 
and at harvest.  
 
 
3.5  Management of the vaginal mucosa specimens  
 
Thirteen fresh human vaginal mucosal specimens were obtained from excess 
tissue removed during vaginal hysterectomies and corrective procedures in 
postmenopausal women at the theatres of the Department of Gynaecological 
Oncology, Tygerberg Hospital. The patients were briefly informed about the 
possibility of passively participating in this study by donating excess vaginal 
tissues resulting from the hysterectomy procedure for implantation into the 
nude mice. In particular it was made clear to the patient that no extra tissue 
would be harvested other than that is routinely included in hysterectomy 
specimens. All published data will remain anonymous (see Appendix IV: 
patient consent form). 
 
The harvested vaginal tissues were clinically and macroscopically verified for 
any diseases before being prepared as xenografts. The specimens were 
immersed in Transport Medium (TM -see Appendix V), and transported to our 
laboratory (Fig 7). Each specimen was divided into 2 portions, one (A) to 
construct the experimental cyst and the other (B) for control by histological 
examination (Fig 8). 
 
Specimen A was trimmed to pieces of approximately 18x8 mm and, by using 
a scalpel, the excess supporting connective tissue was separated as carefully as 
possible from the epithelium in order to preserve the integrity of the latter (Fig 
9A, B). The specimen (consisting mainly of epithelium) was then placed in a 
sterile solution of 3mM disodium ethylenediaminetetraacetic acid (EDTA) in 
Dulbecco’s calcium and magnesium-free phosphate saline (PBS) (see 
Appendix VI) and maintained for 2 hours in a shaker bath at 37°C in order to 
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achieve complete separation of the epithelial and connective tissue 
components (Fig 9C).     
 
Specimen B (control portion) was fixed in 10% saline-buffered formalin and 
routinely processed for embedding, cutting, staining and histological 
examination by the NHLS histopathology laboratories at Tygerberg Hospital. 
The sections was evaluated for pathological abnormalities and kept for 
comparison purposes (see Appendix VII: Evaluation form of donated vaginal 
tissue). 
 
The containers for TM (Fig7) and For EDTA (Fig9C) were sterilised by 
1%Virkon before using. 
 
  
Figure 7: Donated vaginal mucosa, immersed in transport medium. 
 
 
Figure 8: Two portions of donated vaginal mucosa 
 
Specimen B 
Specimen A 
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Figure 9A: Separating connective tissue from epithelium by using the scalpel 
Figure 9B: Completed separation of connective tissue from epithelium. 
Figure 9C: Epithelium was immersed in 3mM EDTA for 2 hours. 
  
Connective Tissue 
Epithelium 
A 
B 
C 
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3.6  Artificial cyst creation and implantation  
 
3.6.1 The construction of the artificial cysts (Fig 10) 
The construction of the artificial cysts was accomplished at the sterilized 
laminar air-flow unit. Pre-cut 5mm segments of silicone tube of 5mm in 
diameter were gas-sterilised with ethylene oxide in glass containers enclosed 
in sealed envelopes at the Oral Health Center (Tygerberg) of the University of 
the Western Cape. These tube segments were placed on the surface of the 
epithelial specimens that were then wrapped around it and tied with a silk or 
nylon suture (5-0) tied so that the silicone tube (5mm) segment became 
enclosed in the artificial cyst. The artificial cysts were then placed in fresh 
transport medium and kept ready for implantation. 
 
 
3.6.2 The procedures of the implantation (Fig 11) 
Forty-three specimens were implanted during the study. The athymic mice 
(MFI nu nu ex University of the Witwatersrand) were transferred frome the 
isolator to the laminar air-flow unit where the operations were carried out. The 
mice were anaesthetised with a mixture of 10% dilution of Ketamine 
[25mg/kg] and Medetomidine [0.5mg/kg] in a single intraperitoneal injection 
(see Appendix VIII). The neck region of the mice, where the cysts were to be 
implanted, was cleaned/disinfected with Povidone-iodine solution before an 
incision of 10-15mm was made. A subcutaneous pocket was prepared under 
the skin by blunt dissection. The artificial cysts were carefully placed into the 
prepared pockets and the wound was sutured with 5-0 silk or nylon. The mice 
were administered intramuscularly once with Penicillin-G (100 units/g) 
immediately after the surgery.  
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 Figure 10 A): The instruments of the implantation 
  
 
  
Figure 10 B): The silicone tube plated on the epithelium surface;  
10 C-E): The construction of the artificial cyst 
 
Figure 10 F) The artificial cyst was immersed into TM; 
A
B 
D E 
F 
C
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Figure 11 A, B: Transfer mice from the isolator to the laminar flow unit. 
  
Figure 11 C, D: The applied anaesthetics in this study: Anaket-V® [ketamine 
100mg/ml], Domitor® [medetomidine 1mg/ml], ISOFOR® [Isofluurane].  
 
 
Figure 11 E: All operations were carried out in the laminar flow unit.  
 
 
 
A B 
C D
E
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Figure 11 F-K: The implantation procedure. 
 
 
 
 
 
G 
H I 
J K 
F
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3.7  Injection of Gentamicin 
 
The 20 mice of Groups 1 and 3 were administered subcutaneously with 
Gentamicin (1mg/100 bodyweight) twice daily for a postoperative period of 
14 days. The injections were performed inside the isolator. To prevent 
suffering, the animals were briefly anaesthetised with Isoflurane vapours 
(0.02% density -Fig 12A) before Gentamicin was administered. 
 
 
  
Figure 12: Photo showing gentamicin injection under anaesthesia. 
A: Prior to the injection the animals were anaesthetized with 0.2 ml Isoflurane 
vapourised in a 1000ml beaker inside the isolator.  
B: The Gentamicin was administered subcutaneously in the back (twice daily). 
 
A B
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3.8  Microbiological testing 
 
3.8.1 Microbiological testing of the animals 
Microbiological samples of each experimental site were obtained by swabbing the 
following sites:  
1) The skin of the neck prior to cleaning with Povidone-Iodine disinfectant and 
the implantation procedure. 
2) The skin around the wound at sacrifice after the operation. 
3) The inside of the cyst at donor site after harvesting. 
 
3.8.2 Microbiological testing of the operation procedure 
In order to assess the sterile conditions of the cyst preparation and implantation 
procedures, microbiology samples were obtained during the critical phases 
including the swabbing of the human vaginal tissue before separation, the 
epithelium after EDTA treatment, the artificial cysts before implantation, the 
wound and skin of the donor site, and the instruments used.  
 
3.8.3 Microbiological testing of the investigators’ nasal passages   
The only one opportunity for animals to be in contact with humans was during the 
implantation operation. The investigators’ nasal passages were swabbed to 
determine their staphylococcus carrier state.  
 
3.8.4 Microbiological testing of the air of the animal room and isolators 
Because of logistical problems with the animal housing facilities at Tygerberg 
campus, the study could only be carried out in a substandard animal room in the 
Department of Medical Bioscience on the campus of the University of the 
Western Cape. There were many examination and test papers stored at one side 
of the room (Fig 13). The ability of the isolators to keep strict germfree 
conditions was tested by taking microbiology samples of the air outside and 
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inside the isolator by placing culture medium dishes in the animal room and 
inside the isolators for 2 hours.  
 
 
 
Fig 13: The substandard animal room. Stacks of examination papers and 
notes were stored at the corner of the room (arrow). 
 
 
3.8.5 Microbiological testing of the sterilized rodent food and bedding 
The sterilized food and bedding were transferred into the isolators usually 5 hours 
after autoclaving, allowing for 3 hours of cooling down and 2 hours of 
sterilization of the port between the autoclave and the isolator. The efficiency of 
the food autoclave unit was estimated at the beginning of the experiments by 
submitting small pieces of food and bedding taken 5 hours after autoclaving for 
microbiological examination.  
 
All the samples were sent to the NHLS microbiology laboratories at Tygerberg 
for microscopical evaluation, culturing, subculturing (Staphylococcus and 
Streptococcus spp.) and further antibiotic sensitivity testing if bacterial growth 
had been identified.  
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3.9  Histological evalution 
 
The tissue specimens from the all experimental groups and the control group 
were assessed for the success or failure of the xenograft procedure by 
recording/measuring the: 
1. Vitality of the xenografts (absence or presence of necrosis), 
2. Presence or absence of cyst formation by assessing the potency of the 
lumen and comparing the epithelial thickness and structure between the 
xenografted cysts and the original vaginal mucosa control tissues,  
3. Presence or absence of fibrosis in the cyst wall and the adjacent donor site, 
4. Establishment of new blood supply to the implanted connective tissue 
which has a bearing on the nutritional capacity of the cyst model and the 
correct functioning of the epithelium, 
5. Presence or absence of infection and /or inflammation under the basal 
membrane of the cyst wall and in the cyst lumen. This was correlated to 
the routine microbiological information pertaining to each experimental 
animal. Gram stains were applied to the tissue sections when there has 
been clinical or histological evidence of infection. 
 
The histological observation and comparison of the control vaginal mucosa 
with the cyst lining were determined by 2 observers using code-labelled 
slides. The procedure was performed in duplicate (see Appendix IX: 
Evaluation form of cyst wall). 
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3.10  The endpoint of the animal model 
 
After 9 weeks of growth, when the healing around the cysts was complete, the 
mice were euthanatized by an overdose of Isoflurane (0.12% density). At harvest, 
the cysts were excised with overlying skin and surrounding soft tissues, the cysts 
were opened and the lumen swabbed for microbiological testing. Thereafter the 
tissues were fixed in 10% formalin for histological processing, sectioning and 
staining by the NHLS histopathology laboratories at Tygerberg hospital. 
 
As already mentioned above, the endpoint of the experiments was reached after 
the 9 weeks post-implantation period. It was anticipated that a number of the 
artificial mucosal cysts, which were implanted in the neck region of the athymic 
nude mice, would become infected, especially in the control group and perhaps 
(but hopefully fewer) in the experimental groups. The animals were continuously 
and carefully assessed for their general health status; in particular they were 
monitored for 1) acute and chronic infection, 2) consistent or rapid body weight 
loss of 20% maintained for 72 hours, 3) signs of chronic pain and physiological 
stress: persistent anorexia, inability to move, unconsciousness, comatose or failure 
to respond to gentle stimuli. When any of the above signs had clinically crossed 
the humanely acceptable thresholds in a particular (single or group of) 
experimental animals before the 9 week post-operative healing period was over, 
the nude mice were fully anaesthetised (see above description) and killed by an 
overdose of Isoflurane. This was followed by post-mortem examinations and 
histological/ microbiological analyses of the (failed or diseased) implant. We 
anticipated a 25% loss of the experimental animals due to various causes; all lost 
animals were subjected to a post-mortem examination with histopathology. 
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3.11  Abbreviated research ethics statement 
 
The laboratory animals were as humanely as possible taken care of during the 
experiments. The animals live, grow, reproduce and interact under conditions and 
circumstances in which their species’ specific needs are met. Experimental 
procedures, which cause injury, disease, discomfort, fear, or pain, will keep 
exposure of animals to these conditions to a minimum. The care of experimental 
animals was under the direct control and supervision of a qualified laboratory 
animal technician. High standards were maintained in the daily care of 
experimental animals. The experimental animals were kept in optimal conditions 
at all times including good housing, correct environmental conditions with 
acceptable space for movement and provision for the gratification of their 
physical and etiological requirements. The professional animal technician was 
responsible for the pre- and post-operation care. All investigators in this study had 
experience with using animals in medical or dental research. At the end of the 
study, the animals were euthanised with Isoflurane (0.12% density in one 250ml 
flask). 
 
Ethics clearances of the study were obtained from both the University of the 
Western Cape and University of Stellenbosch. 
 
Project registration numbers: N05/04/061 (UWC) and P05/04/003 (US) 
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CHAPTER 4: RESULTS  
4.1 Animal housekeeping and observations 
 
Fifty-three athymic nude mice were transported to the laboratory at UWC and 
housed in the isolators. In general the animals survived the experiments quite well 
and no major problems were encountered in housekeeping. Aggression (climbing 
onto the cage cover and jumping), repetitive roaming behaviour, nervousness and 
handling difficulties were observed in some of the mice. Most of mice made their 
nest in the shadow of the food hopper and/or drinking bottle. The implantation 
sites at the neck region of some mice could be scratched with their rear paws or 
scraped by the steel food hopper.  
 
Ten animals were lost before the implantation due to transport-associated 
problems and anaesthetic issues. Three mice with implants in the control group 
were euthanised after 3 weeks as severe inflammation around the opened wounds, 
persistent anorexia, and inability to move or impairment was observed. Another 3 
implanted mice (two in Group 2 and one in the control group) were lost because 
of lung injury by peracetic acid respectively at 5 days, 22 days and 43 days (see 
table 2). 
 
Of the other 37 mice with implants harvested at 9 weeks, 14 implants were 
re-established as intact cyst formation. There was no distinct difference between 
Terramycin/vitamin cocktail group and the control group. Meanwhile, 64.3% 
cases with intact cyst formation were administered with Gentamicin after the 
implantation. The histological structure of the harvested cysts will be described in 
detail in §4.3. 
 
Eight implants resulted in partial cyst formation with partial necrosis or ingrowth 
of murine epidermis into the cyst cavity (Figs 14 A-C). Eight implants were 
associated with poor wound healing resulting in scabbed artificial cysts or full loss 
of the implanted cysts (Fig 15). 
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Table 2: Evaluation of the animals and implants 
 
 
 
 
 
Harvest at 9 weeks Before harvest 
Total Intact 
cyst 
formation 
Partial 
Cyst 
formation 
Atrophic 
cyst 
Necrotic 
cyst 
Poor 
wound 
healing 
Eutha- 
nised 
Lost 
Group 1 
(Terramycin+Gentamicin) 
5 1 1 1 2   10 
Group 2 
(Terramycin) 
2 4   4  2 12 
Group 3 
(Gentamicin) 
4 2 1 1 2   10 
Control Group 3 1 1 2  3 1 11 
Total 14 8 3 4 8 3 3 43 
Lost before implantation   10 
 
 
 
 
Fig.14A: The implanted site with ingrowth of the epidermis and nodular scar 
tissue around the wound.   
 
 
 
 
 A 
14 A 
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Fig.14B: Keratinized stratified squamous surface epithelium ingrowth into cyst 
cavity and lining scar tissue (arrows) (H&E, magnification x20).  
Fig.14C: Keratinized stratified squamous surface epithelium of murine epidermal 
origin lining the cyst cavity and scar tissue (arrow) (H&E, magnification x20).  
 
  
 
Figure 15A: Cyst necrosis and extrusion/sequestration of silastic tube (arrow) due 
to poor wound healing. 
Figure 15B: No implanted cyst was present at the donor site (arrow) (H&E, 
magnification x 40). 
14B  14C 
15A  15B  
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Table 3: The outcome details of all of the implants. 
Group Vaginal Tissue No Implants No Batch Suture* Result** 
1 
 
(T&G) 
 
T240806 A24080602 6 S Necrotic 
 A24080604 6 S CF 
T250806 A25080601 7 S Opened 
 A25080603 7 S Opened 
 A25080605 7 S CF 
T070906 A07090602 8 S AC 
 A07090604 8 S CF 
T280906 A28090602 9 N CF 
 A28090604 9 N CF 
 A28090606 9 N IG&PCF 
2 
 
(T) 
T050506 A05050601 1 N CF 
T180506 A18050603 3 N CF 
 A18050601 1 N Opened 
T260506 A26050601 3 N PCF 
T150606 A15060601 4 N Lost 
T230606 A23060601 4 N IG&PCF 
T060706 A06070601 4 S Opened 
 A06070603 5 S IG&PCF 
T280706 A28070601 5 S IG&PCF 
T030806 A03080601 5 N Opened 
T110806 A11080601 6 S Lost 
T240806 A24080606 7 S Opened 
3 
 
(G) 
T240806 A24080601 6 S Opened 
 A24080603 6 S Necrotic 
 A24080605 6 S Opened 
T250806 A25080602 7 S CF 
 A25080604 7 S IG&PCF 
T070906 A07090601 8 S CF 
 A07090603 8 S CF 
 A07090605 8 S AC 
T280906 A28090601 9 N IG&PCF 
 A28090603 9 N CF 
 
C  
O 
N 
T  
R  
O 
L 
 
 
T050506 A05050602 1 N CF 
T180506 A18050605 3 N PCF 
 A18050604 1 N Euthanised 
T250506 A25050601 3 N Necrotic 
T260506 A26050602 3 N CF 
T150606 A15060602 4 N AC 
T230606 A23060602 4 N Necrotic 
T060706 A06070602 5 S Euthanised 
 A06070604 5 S Euthanised 
T030806 A03080602 5 N Lost 
T280906 A28090605 9 N CF 
*Suture used: silk (S) and nylon (N) 
**AC=atrophic cyst; ICF=intact cyst formation; PCF=partial cyst formation; IG=ingrowth of 
mouse epidermis; Necrotic= cyst epithelium necrosis; Opened = poor wound healing; Euthanised 
=mice were euthanised because of the severe inflammation with poor wound healing before 9 
weeks; Lost=implanted mice died before the wounds healed completely. 
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4.2 Microbiological testing 
4.2.1 The results of the skin swab before operation (Sample A) 
The microbiological testing of animal skins before the implantation was 
undertaken in 43 mice. The presented rate of contaminants was 72.1% (31 mice). 
Organisms were isolated from 31 unoperated mice in 45 instances.   
 
Table 4: Detail of the identification and antibiotic sensitivity testing of sample A 
 
Group Animal No Batch Identified contaminants Penicillin Gentamicin Tetracycline Vancomycin 
1 
(T&G) 
A24080602 6 -     
A24080604 6 -     
A25080601 7 Klebsiella pneumoniae S S   
A25080603 7 Enterococcus species S   R 
A25080605 7 CNS mixed S S R S 
A07090602 8 CNS mixed S S R S 
A07090604 8 CNS mixed S S R S 
A28090602 9 Klebsiella pneumoniae S S   
A28090604 9 Enterococcus species S S S R 
A28090606 9 Enterococcus species S S S R 
  Klebsiella pneumoniae R S   
 
 
 
 
 
 
 
2 
(T) 
 
 
 
 
 
 
 
 
 
A05050601 1 -     
A18050603 3 -     
A18050601 1 -     
A26050601 3 Enterobacter cloacae R S   
A15060601 4 Klebsiella pneumoniae R S   
  Pseudomonas aeruginosa  S   
A23060601 4 Klebsiella oxytoca R S   
  Pseudomonas aeruginosa  S   
A06070601 4 Klebsiella pneumoniae R S   
  Pseudomonas aeruginosa  S   
A06070603 5 Staphylococcus sciuri S S R S 
A28070601 5 Staphylococcus sciuri R S R S 
A03080601 5 Staphylococcus aureus S S S S 
  Klebsiella pneumoniae R S   
  Pseudomonas aeruginosa  S   
A11080601 6 Enterobacter cloacae S   R 
A24080606 7 -     
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Group Animal No Batch Identified contaminants Penicillin Gentamicin Tetracycline Vancomycin 
3 
(G) 
A24080601 6 -     
A24080603 6 Proteus mirabilis S S   
  Pseudomonas aeruginosa  S   
A24080605 6 Klebsiella pneumoniae R S   
A25080602 7 Staphylococcus aureus S S S S 
A25080604 7 -     
A07090601 8 -     
A07090603 8 Pseudomonas aeruginosa  S   
  β-haemolytic Strep grp A S   S 
A07090605 8 β-haemolytic Strep grp A S   S 
  CNS mixed S S R S 
A28090601 9 Staphylococcus aureus S S S S 
  β-haemolytic Strep grp A S   S 
A28090603 9 Klebsiella pneumoniae R S   
C 
A05050602 1 Enterococcus species S    
A18050605 3 -     
A18050604 1 -     
A25050601 3 -     
A26050602 3 Staphylococcus aureus S S S S 
A15060602 4 Klebiella species R S   
  Enterobacter cloacae R S   
A23060602 4 Klebiella pneumoniae R S   
  Pseudomonas aeruginosa  S   
A06070602 5 Klebiella pneumoniae R S   
  Pseudomonas aeruginosa  S   
A06070604 5 Klebiella pneumoniae R S   
  Pseudomonas aeruginosa  S   
A03080602 5 Staphylococcus gallinarum    S 
A28090605 9 Enterobacter cloacae R S   
*s=susceptible; r=resistant.  
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Table 5: Summary table of the result of Sample A as identified per batch 
 
 
*All animals in Batch 2 died of low temperature during the airfreight on the 
second day after arrival.  
**Unequal between total number of contaminants and the implants.  
 
 
Abbreviations f Contaminants 
 
ENTCL: Enterobacter cloacae 
ENTFE: Enterococcus faecalis 
KLEOX: Klebsiella oxytoca 
KLEPN: Klebsiella pneumoniae 
PSEAE: Pseudomonas aeruginosa 
STAAU: Staphylococcus aureus 
 
STASC: Staphylococcus sciuri 
STAGA: Staphylococcus gallinarum 
STAXY: Staphylococcus xylosus 
PROMI: Proteus mirabilis 
BHSA: β-haemolytic streptococcus group A 
 
 
 
The contaminants were mainly normal commensals of healthy experimental 
animals: Pseudomonas aeruginosa (25.5%) was the most frequently isolated, 
followed by Klebsiella pneumoniae (20%), Enterobacter cloacae (8.9%), 
Enterococcus faecalis (8.9%), Klebsiella oxytoca (2.2%) and Proteus mirabilis 
(2.2%). Staphylococus aureus and Streptococci were only found in 3 mice (6.7%). 
Coagulase negative staphylococcus was the most commonly isolated pathogenic 
Batch Batch 
1 
Batch 
2* 
Batch 
3 
Batch 
4 
Batch 
5 
Batch 
6 
Batch 
7 
Batch 
8 
Batch 
9 Total 
Date of arriving 25/4 2/5 9/5 23/5 6/6 13/6 8/8 29/8 12/9 
 
 
O 
R 
G 
A 
N 
I 
S 
M 
S 
No 
contaminants 3  3   3 2 1  12 
Id
en
tif
ie
d 
co
nt
am
in
an
ts
 
ENTCL   1 1  1   1 4 
ENTFE 1      1  2 4 
KLEOX    1      1 
KLEPN    4 3 1 1   9 
PSEAE    4 3 1  1 3 12 
STAAU   1  1  1  1 4 
STASC     2  1 3  6 
STAGA     1     1 
PROMI      1    1 
BHSA        2 1 3 
Total** 1  2 10 10 4 4 6 8 45 
M 
I 
C 
E 
Implanted in 
Batch** 4  5 5 6 6 6 5 6 43 
Lost before 
microbiological 
testing 
2 6  1    1  10 
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organism (17.8%). High levels of Klebsiella pneumoniae were found in batches 4 
and 5; Pseudomonas aeruginosa was mainly found in batches 4, 5 and 9, and 
β-haemolytic streptococcus group A was only collected from batches 8 and 9.  
 
The antibiotic sensitivity test for these identified contaminants in Table 4 show 
that all kinds of contaminants, except for Klebsiella species, Enterobacter cloacae, 
and Pseudomonas species, were susceptible to Penicillin; only Staphylococcus 
aureus was susceptible to Terramycin (5% oxytetracycline); and all bacteria, 
except for β-haemolytic streptococci group A, were susceptible to Gentamicin. 
The latter were also found to be sensitive to Penicillin and Vancomycin. All 
Staphylococci species were sensitive to Vancomycin.  
   
 
 
4.2.2 The results of the skin swab after implantation (Sample B) 
 
The reports of all specimens taken from the sutured wound area after the 
implantation showed no growth. The skin of the implantation site was disinfected 
with Povidone-Iodine solution prior to incision. 
 
 
 
4.2.3 The results of the cyst swab (Sample C)  
 
The contents of the cysts of three mice were not swabbed because they had died 
from Peracetic acid poisoning before cyst growth and surgical wound healing took 
place. 
 
 
 
 
 
 41
 
Table 6: Detail of the identification and antibiotic sensitivity testing of sample C 
 
Group Cyst No Result Identified contaminants Penicillin Gentamicin Tetracycline Vancomycin 
1 
A24080602 Necrotic Staphylococcus sciuri S S R S 
A24080604 CF -     
A25080601 Opened CNS mixed S S  S 
A25080603 Opened Staphylococcus xylosus S S R S 
A25080605 CF CNS mixed S S  S 
A07090602 Necrotic Staphylococcus sciuri R S R S 
A07090604 CF -     
A28090602 CF -     
A28090604 CF -     
A28090606 IG&CF Enterococcus faecium S   S 
2 
A05050601 CF Staphylococcus sciuri S S R S 
A18050603 CF Staphylococcus xylosus R S R S 
A18050601 Opened Staphylococcus xylosus R S R S 
A26050601 CF Staphylococcus gallinarum     
A15060601 Lost No collection     
A23060601 IG&CF CNS mixed S S  S 
A06070601 Opened CNS mixed S S  S 
A06070603 IG&CF CNS mixed S S  S 
A28070601 IG&CF Enterococcus faecalis S S   
A03080601 Opened Pseudomonas aeruginosa  S   
A11080601 Lost No collection     
A24080606 Opened Pseudomonas aeruginosa  S   
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Group Cyst No Result Identified contaminants Penicillin Gentamicin Tetracycline Vancomycin 
3 
A24080601 Opened Staphylococcus aureus S S  S 
A24080603 Necrotic CNS mixed S S  S 
A24080605 Opened Staphylococcus gallinarum S S  S 
A25080602 CF -     
A25080604 IG&CF CNS mixed S S  S 
A07090601 CF -     
A07090603 CF -     
A07090605 Necrotic Staphylococcus gallinarum S S  S 
A28090601 IG&CF Entercoccus faecalis S   S 
A28090603 CF -     
C 
A05050602 CF Staphylococcus aureus S S S S 
  Enterococcus faecalis S   S 
A18050605 CF -     
A18050604 Euthasia Enterococcus faecalis S R S  
A25050601 Necrotic CNS mixed S S S S 
A26050602 CF Staphylococcus aureus S S S S 
A15060602 CF -     
A23060602 Necrotic CNS mixed S S S S 
A06070602 Euthasia Pseudomonas aeruginosa  S   
A06070604 Euthasia Enterobacter cloacae R S   
A03080602 Lost No collection     
A28090605 CF Enterococcus faecalis S   S 
*R=resistant; s=susceptible. 
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Table 7: Summary table of the results of Sample C 
 
*Unequal between total number of contaminants and the implants. 
 
 
Abbreviations of Contaminants:  
 
ENTFE: Enterococcus faecalis,  
PSEAE: Pseudomonas aeruginosa,  
STAAU: Staphylococcus aureus,  
CNS: Coagulase negative Staphylococcus,  
STASC: Staphylococcus sciuri, 
STAGA: Staphylococcus gallinarum,  
STAXY: Staphylococcus xylosus 
 
 
Staphylococcus aureus, Coagulase negative staphylococcus spp (S. sciuri. S. 
gallinarum, S. xylosus), Enterococcus faecalis, and Pseudomonas aeruginosa 
were isolated at implanted sites where they induced wound infections. Only ten 
implant cases had no contamination inside the implanted cysts. There were 4 
implants without contaminants in both Group1 and Group 3, which were both 
administered with Gentamicin injections. Twenty-one implants harboured 
Staphylococcus species and 18 of them contained coagulase-negative species. 
Coagulase negative staphylococcus species were isolated from groups 1 and 2, 
which were given Terramycin/vitamin cocktail, and were resistant to 
Terramycin. Pseudomonas aeruginosa was only isolated from opened wound 
sites. Enterococcus faecalis species were collected both from implants with 
Group 
Group1 
(T&G) Group2 (T) 
Group3 
(G) 
Control 
Group Total 
No contaminants 4  4 2 10 
Id
en
tif
ie
d 
co
nt
am
in
an
ts
 
ENTFE 1 1 1 4 7 
PSEAE  2  1 3 
STAAU   1 2 3 
CNS mixed 2 3 2 2 9 
STASC 2 1   3 
STAXY 1 2   3 
STAGA  1 2  3 
Total* 6 10 6 9 31 
Animal number * 10 10 10 10 40 
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epidermis ingrowth and inside well healing wounds. Klebsiella species and 
β-haemolytic strepoccci group A were not detectable at the implanted sites after 
9 weeks (See Table 6 for details).  
 
4.2.4 Microbiological testing of the operation procedure and investigators’ 
nasal passages 
 
All samples taken from the constructed cysts, transport medium, instruments and 
worksurface during the operative procedures showed no growth. No Staphylococci 
aureus growth was isolated from the investigators’ nasal passages. 
 
4.2.5 Microbiological testing of the animal room and isolators 
 
Two colonies of bacteria were grown on plate exposed to the ambient air of the 
animal room. The subculture and identification of the colonies were unfortunately 
not reported by the Microbiology laboratory. All reports on samples taken from 
the air inside the 3 isolators showed no growth.  
 
4.2.6 Microbiological testing of the food and bedding 
 
The reports on samples taken from the food and bedding also showed no bacterial 
growth. 
 
 
4.3  The change of animals’ body weight   
 
The body weight was an important parameter for evaluating the health of all the 
experimental animals. Every animal was weighed before the operation, after 14 
days of injections in case of Gentamicin injections (Groups 1 and 3), and at 
harvest. 
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Table 8: Weight change of Control Group 
 
Implants Number Weight at implant (g) Weight at harvest (g) Change (g) Percent 
A05050602 20 28 +8.0 +40.00% 
A18050605 23 31.2 +8.2 +35.65% 
A18050604* 18 23 +5.0 +27.78% 
A25050601 28 36.4 +8.4 +30.00% 
A26050602 24 33.7 +9.7 +40.42% 
A15060602 27 30 +3.0 +11.11% 
A23060602 27 27 0 0 
A06070602** 29    
A06070604** 28    
A03080602*** 22    
A28090605 28 33.1 +5.1 +18.21% 
MEAN 24.9  30.3 +5.9 +23.79% 
SD   3.3  
*Serious inflammation around the opened wound. Mouse was killed at 3 weeks. 
**Serious inflammation around the opened wound. Mice killed at 3 weeks. Body weight lost 
respectively 1.3g and 0.5g. 
***Dead of the lung injury by 4% Peracetic Acid at 22 days. Body weight increased 2g. 
 
 
Table 9: Weight change of Group 2 (Terramycin/vitamin water)  
 
Implants Number Weight at implant (g) Weight at harvest (g) Change (g) Percent 
A05050601 21 29 +8.0 +38.10% 
A18050601 23 32.4 +9.4 +40.87% 
A18050603 25 34.6 +9.6 +38.40% 
A26050601 17 27.1 +10.1 +59.41% 
A15060601* 25    
A23060601 26 28 +2.0 +7.69% 
A06070601 29 32 +3.0 +10.34% 
A06070603 27 31.5 +4.5 +16.67% 
A28070601 24 25 +1.0 +4.17% 
A03080601 26 26.7 +0.7 +2.69% 
A11080601* 28    
A24080606 24 28 +4.0 +16.67% 
MEAN 24.2 29.4 +5.2 +21.61% 
SD   3.7  
* Dead of the lung injury by 4% Peracetic Acid respectively at 43 days and 5 days after the operation. 
Body weight lost respectively 1.6g and 0.8g. 
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The mean increase of the body weight in the Terramycin/vitamin drink group 
(Group 2) was 5.2 grams, which is not significantly different to the 5.9 grams in 
the control group without any antibiotic coverage during the postoperative period.  
 
Table 10: Weight change of Group 3 (Gentamicin) 
 
Implants 
number 
Weight at 
implant (g) 
Weight after 
14 days (g)
Change Weight at 
harvest (g)
Change* 
g Percent g Percent 
A24080601 30 28 -2.0  -6.67% 30.3 +0.3 +1.00% 
A24080603 26 24 -2.0  -7.69% 25.3 -0.7 -2.69% 
A24080605 22 21 -1.0  -4.55% 23 +1 +4.55% 
A25080602 21 21 0  0 24 +3 +14.29% 
A25080604 25 25 0 0 26 +1 +4.00% 
A07090601 20 20 0 0 23 +3 +15.00% 
A07090603 19 21 +2.0 +10.53% 28 +9 +47.37% 
A07090605 16 19 +3.0 +18.75% 22 +6 +37.50% 
A28090601 24 26 +2.0 +8.33% 30.8 +6.8 +28.33% 
A28090603 26 28 +2.0 +7.69% 29.8 +3.8 +14.62% 
MEAN 22.9  +0.4 +1.75% 26.2 +3.3 +14.50% 
SD   1.8    3.1   
*The change is between the weight at harvest and the weight at implant time. 
 
 
Table 11: Weight change of Group 1 (both antibiotics) 
 
Implants number Weight at implant(g)
Weight 
after 14 
days (g) 
Change Weight at 
harvest 
(g) 
Change* 
g Percent g Percent 
A24080602 31 30 -1.0 -3.23% 32.5 +1.5 +4.84% 
A24080604 21 21 0 0 20.4 -0.6 -2.86% 
A25080601 24 23 -1.0 -4.17% 26.5 +2.5 +10.42% 
A25080603 21 22 1.0 4.76% 24.4 +3.4 +16.19% 
A25080605 25 25 0 0 28.4 +3.4 +13.60% 
A07090602 18 20 2.0 11.11% 22 +4 +22.22% 
A07090604 16 16 0 0 22 +6 +37.50% 
A28090602 27 28 1.0 3.70% 32.5 +5.5 +20.37% 
A28090604 27 27 0 0 31.4 +4.4 +16.30% 
A28090606 24 24 0 0 27.1 +3.1 +12.92% 
MEAN 23.4  0.2 0.85% 26.7 +3.3 +14.19% 
SD   0.9  4.5 1.9  
*The change is between the weight at harvest and the weight at implant. 
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The mean increase in body weight in Groups 1 and 3 after both were administered 
with Gentamicin injections were very similar; the changes in body weight after 14 
days injections were respective 0.4 grams and 0.2 grams. Among them, the weight 
of 7 mice increased, of 5 decreased and of 8 remained even. The increase in body 
weight was less than that for the groups without Gentamicin injections, but not 
statistically significant.  
 
4.4 Histological evaluation of the cyst wall 
 
Twenty-two of 37 implants which were harvested at 9 weeks yielded intact or 
partial cyst formation in this study. At 9 weeks the implanted artificial cysts were 
surrounded by mouse connective tissue. The non-keratinised stratified squamous 
epithelium (SSE) was microscopically similar to that of the vaginal mucosa from 
which the cysts were constructed (Fig 16). 
 
Figs 16A: Photomicrographs of intact cyst formation with varying thickness of 
stratified squamous epithelium after 9 weeks growth (H&E, magnification x20)  
 
 
 
16A 
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Figure 16B): Histology showing that the epithelium of the cyst maintained the 
structure of the human vaginal mucosa. (H&E, magnification x100) 
 
Figure 16 C): Non-keratinised SSE of the cyst, a=basal cell layer, b=parabasal cell 
layer, c=intermediate cell layer, d=superficial, parakeratinising cell layer. (H&E, 
magnification x200) 
 
 
The cyst epithelium was similar to the control vaginal tissue albeit flattened 
orthokeratotic or hyperparakeratotic, lacking rete pegs (Fig 17, 20) and exhibiting 
nodules of thickened epithelium in the cyst wall (Fig 19). However, a few rete 
pegs had developed in one cyst (Fig 21). The cell layers of the cyst epithelium are 
loosely arranged, and desquamation of the surface epithelial cells into the lumen 
is noticed in most cysts in this model (Fig 18). The majority of the thicker 
16 B 
16C 
 
a 
 
c 
d 
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epithelial regions of the cyst lining contained nodular or plaque-like epithelial 
thickenings (Fig 19), which were not deemed due to tangentially sectioning. The 
maximum and minimum cell layers were observed in 12 random foci of the 
epithelia of the control vaginal tissues and the derived cyst walls. There was no 
statistic difference in the number of the cell layers between the epithelial lining of 
cysts and the control vaginal epithelium. The results are recorded in Tables 12 and 
13.  
 
 
Figure 17 A: Photomicrograph of the vaginal mucosa processed as control 
tissue (H&E, magnification x100). 
 
 
 
Figure 17 B: Cyst lining derived from the same vaginal mucosa specimen 
(A) after 9 weeks growth (H&E, magnification x100). 
A 
B 
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Figure 18A: Photo of a larger amount of keratin in the cyst lumen  
Figure 18B: Photomicrograph of desquamation of the epithelial cells into 
the lumen. (H&E, magnification x40) 
 
 
 
Figure 19: Photomicrograph of nodular epithelial thickening at the 
thick region of the cyst (H&E, magnification x100). 
A 
B 
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Figure 20: Photomicrograph of 3 cysts (B-D) constructed from one donated 
vaginal tissue (A). B&D) flattened and lifting off cyst epithelium; C) 
hyperkeratotic cyst epithelium (H&E, magnification x100)  
 
 
 
Figure 21: Photomicrograph of few rete pegs that had formed. (H&E, 
magnification x20) 
 
A B 
C D 
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Ulceration of the epithelium (Fig 22A), partial epithelium necrosis (Fig 22B) and 
ingrowth of the mouse epidermis (Fig 22C) were observed in the implants with 
partial cyst formation.  
 
 
 
  
 
Figure 22A: Photomicrograph of ulcer of epithelium (arrow) (H&E, magnification x40) 
Figure 22B: Photomicrograph of necrotic epithelium (arrow) (H&E, magnification x200) 
Figure 22C: Photomicrograph of transformation between non-keratinized cyst epithelium 
(thick arrow) and keratinised epidermis (thin arrow). (H&E, magnification x100) 
A 
B 
C 
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Table 12: The thickness of the control human vaginal epithelium 
 
 
Tissue No 
maximum number of cell layers minimum number of cell layers 
1 2 3 4 5 6 7 8 9 10 11 12 AV SD 1 2 3 4 5 6 7 8 9 10 11 12 AV SD 
T05050601 19 21 20 22 24 21 21 23 19 21 22 23 21.3 1.56 10 8 8 9 11 14 10 10 7 6 8 7 9.0 2.17
T18050601 21 20 24 23 22 24 24 21 23 20 22 24 22.3 1.56 6 12 6 7 8 8 7 9 7 11 7 9 8.1 1.88
T25050601 21 24 25 24 21 20 23 20 26 23 20 22 22.4 2.07 12 12 8 11 5 13 11 8 8 6 9 10 9.4 2.50
T26050601 21 25 28 27 23 29 24 26 29 22 21 23 24.8 2.95 14 7 9 10 11 11 12 9 10 11 13 12 10.8 1.91
T23060601 20 21 19 20 24 22 21 20 21 24 20 25 21.4 1.93 12 11 12 8 7 10 8 13 9 9 12 9 10.0 1.95
T06070601 21 23 20 27 23 22 24 23 22 20 22 26 22.8 2.14 12 10 13 14 12 10 15 14 12 14 10 13 12.4 1.73
T28070601 24 25 23 26 22 23 21 23 21 22 20 20 22.5 1.88 14 13 11 12 10 9 11 14 9 12 9 11 11.3 1.82
T03080601 27 19 25 27 21 22 24 22 24 25 20 22 23.2 2.59 10 12 15 13 14 10 13 10 12 13 11 9 11.8 1.85
T24080601 24 26 28 25 30 29 31 27 26 28 24 25 26.9 2.31 13 9 6 10 10 7 11 14 12 9 11 13 10.4 2.43
T25080601 22 27 25 22 23 20 23 26 28 25 27 24 24.3 2.42 13 14 13 15 12 12 11 15 11 13 11 12 12.7 1.44
T07090601 23 25 19 20 21 19 18 22 21 20 23 24 21.3 2.18 12 10 11 8 10 11 13 9 12 12 8 8 10.3 1.78
T28090601 31 29 28 32 25 35 33 30 27 29 31 33 30.3 2.83 16 18 13 15 14 17 16 15 13 8 13 11 14.1 2.75
MEAN             23.6              10.9  
SD             2.66              1.7  
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Table 13: The thickness of the cyst epithelial lining 
Cyst No 
maximum number of cell layers minimum number of cell layers 
1 2 3 4 5 6 7 8 9 10 11 12 AV SD 1 2 3 4 5 6 7 8 9 10 11 12 AV SD 
C05050601 25 24 26 17 19 17 25 23 25 16 17 19 21.1 3.9 12 9 7 5 6 10 10 11 6 7 9 6 8.2 2.29 
C05050602 26 26 28 28 25 30 31 29 25 28 26 27 27.4 1.93 12 8 7 14 12 9 10 12 9 12 11 13 10.8 2.14 
C18050603 27 26 28 29 28 24 25 25 28 24 30 28 26.8 1.99 10 8 6 9 13 11 9 7 12 11 9 8 9.4 2.07 
C18050605 25 27 25 26 28 22 30 22 24 28 27 25 25.8 2.42 9 10 7 8 8 11 7 6 14 11 12 9 9.3 2.35 
C26050601 28 24 25 29 21 26 29 26 28 30 25 24 26.3 2.63 9 10 13 8 7 11 10 11 14 11 12 13 10.8 2.09 
C26050602 23 21 20 22 21 22 19 23 21 19 22 20 21.1 1.38 9 8 8 13 12 8 11 9 10 8 11 10 9.8 1.71 
C23060601 25 26 25 27 24 26 28 24 28 25 27 26 25.9 1.38 5 6 7 4 3 5 5 6 4 5 6 3 4.9 1.24 
C06070603 25 24 27 26 25 22 21 20 26 23 19 18 23.0 2.98 9 10 7 9 8 11 9 7 11 6 9 7 8.6 1.62 
C28070601 8 10 12 14 11 9 11 13 14 10 12 9 11.1 1.98 4 3 5 7 3 4 6 5 4 3 6 5 4.6 1.31 
C24080604 21 26 19 29 23 30 21 18 29 25 27 30 24.8 4.34 6 4 5 5 6 6 8 11 8 5 6 10 6.7 2.15 
C25080602 17 15 14 14 16 18 17 18 14 15 19 16 16.1 1.73 7 7 7 8 9 7 9 10 6 8 9 7 7.8 1.19 
C25080604 27 30 24 29 31 25 31 26 27 28 30 24 27.7 2.57 11 13 10 12 9 13 14 11 10 9 11 13 11.3 1.67 
C25080605 27 25 20 19 18 22 26 20 18 23 24 21 21.9 3.09 12 5 7 6 11 7 8 10 9 5 8 6 7.8 2.29 
C07090601 22 19 23 26 20 23 22 16 24 23 21 18 21.4 2.78 5 6 6 9 7 5 8 7 10 11 9 7 7.5 1.93 
C07090603 20 24 19 18 21 18 19 20 22 25 23 21 20.8 2.29 6 6 8 7 6 4 5 4 4 6 5 8 5.8 1.42 
C07090604 23 22 32 31 28 22 24 26 28 24 25 26 25.9 3.29 10 12 11 14 13 12 14 9 11 13 11 14 12.0 1.65 
C28090601 25 30 29 27 26 23 27 30 26 23 25 29 26.7 2.46 12 11 6 13 12 12 6 7 14 8 7 13 10.1 3.03 
C28090602 18 19 17 21 14 16 18 20 21 17 18 19 18.2 2.04 5 7 10 6 8 7 10 9 8 6 5 8 7.4 1.73 
C28090603 22 21 28 29 24 25 23 27 26 24 21 28 24.8 2.79 6 7 9 10 12 8 8 7 9 11 7 6 8.3 1.92 
C28090604 19 26 18 24 20 25 21 18 23 17 22 25 21.5 3.12 3 12 10 9 6 4 9 7 9 11 9 6 7.9 2.75 
C28090605 20 15 21 16 16 25 18 22 25 23 19 22 20.2 3.43 4 7 4 9 6 7 6 7 5 6 9 9 6.6 1.78 
C28090606 20 21 19 19 18 22 20 18 18 21 20 19 19.6 1.31 11 7 10 7 6 10 5 6 9 10 11 6 8.2 2.21 
MEAN             22.6               8.3  
SD                         4.14               1.9  
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Blood supply has a bearing on the nutritional capacity of the cyst model. The 
thickened regions of the epithelial layer of the cyst usually were associated 
with new blood supply (Fig 23). The re-establishment of the new blood supply 
to implanted artificial cysts might influence the thickness of the cyst 
epithelium.  
 
 
 
Figure 23: Photomicrograph of the new blood supply to implanted 
epithelium. A) Thickened regions of epithelium associated with 
vessel-enriched connective tissue. (H&E, magnification x 40) B) Thinner 
epithelium region with fewer blood vessels (arrows). (H&E, magnification x 
100) 
 
 
 
A 
B 
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The inflammation was still serious even though there were two antibiotic covers 
used in this study. Only 10 of the implanted cysts harvested after 9 weeks growth 
had no contaminants. The other 30 cases contained contaminants at the sites of 
implantation, either in the opened wounds or inside the well healing cysts. 
 
In the cases with opened wounds and/or epidermis ingrowth, the infections were 
due to the uncompleted epidermal wound healing (Fig 24). It was common in the 
well-healed cases that the inflammation was located under the epidermis; 
especially around the skin wound sutures (Fig 25). The ulcerated regions of the 
cysts also contained dense inflammation in the underlying cyst wall (Fig 26).  
 
In those cases with serious inflammation, the inflammatory cells were distributed 
throughout the entire cyst wall and the lumen (Fig 27A, B). In individual cases 
with less inflammation, the inflammatory cells were only located at the base of the 
epithelium (Fig 28).  
 
Sections of the implants from which contaminants were isolated were stained with 
the Gram stain and examined by light microscopy. Colonies of Gram-negative 
Gram-positive bacteria were present in the inflamed cysts (Fig 29). 
 
Serious inflammation was observed in those cases in which silk sutures were used. 
This observation will be described in §4.4 and compared to the cases in which 
nylon sutures were used.  
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Figure 24: Photomicrograph of the epidermis ingrowth and inflammation 
around the wound (arrow). (H&E, magnification x 20) 
 
 
Figure 25A: Low-power photomicrograph of the inflammation in the cyst 
wall close to the murine dermis. (H&E, magnification x 20) 
 
25A 
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Figure 25B: high-power photomicrograph with details of the inflammation around 
the wound suture (arrow). (H&E, magnification x 40) 
 
 
Figure 26: Photomicrograph of the inflammation at ulcerated regions in the cyst 
(arrows) (H&E, magnification x 20) 
 
 
 
25B 
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Figure 27: A) Photomicrograph of moderately dense inflammatory cell 
exocytosis in the cyst epithelium (H&E, magnification x 200); B) 
Photomicrograph of the inflammatory cells (arrow) accumulated in the cyst 
lumen (H&E, magnification x 100) 
 
A 
B 
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Figure 28: Photomicrograph of mild presence of inflammatory cells near base of 
the epithelium (H&E, magnification x 200). 
 
  
Figure 29: Photomicrograph of Gram stains. A) Gram-negative bacteria (pink 
colour); B) Gram-positive bacteria (purple colour) (arrows) (Gram, magnification 
x 1000) 
 
A continuous layer of fibrosis was present between the host connective tissue 
and the implanted cyst in those implants that were constructed from the vaginal 
tissue without 3mM EDTA treatment due to time constraints (Fig 30).  
A B 
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Fibrosis was also present in the sutured areas of the implants (Fig 31). Moreover 
fibrotic human connective tissue was observed filling the lumen of one cyst; the 
epithelial lining was substituted by granulation tissue (Fig32). 
 
 
Figure 30: Photomicrographs of the junction between the murine host connective 
tissue and the human connective tissue of the artificial cyst. A) Fibrosis in the 
implants without EDTA treatment (arrows); B) No fibrosis at same area in the 
implants with EDTA treatment (H&E, magnification x 40) 
 
 
B 
A 
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Figure 31: Photomicrograph of the fibrosis around the suture (arrow). (H&E, 
magnification x 20)  
 
 
Figure 32: photomicrograph of the granulation tissue wall (arrow) surrounding the 
fibrotic lumen contents (H&E, magnification x 20) 
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Three implants with well healing wounds (in Groups 1, 2, 3 each) resulted in 
atrophic cyst formation with an average 3-5 cell layers of cyst epithelium, no 
epithelium necrosis, and without Coagulase–negative staphylococci infection 
(Fig33). In individual cases, epithelial islands were observed in the connective 
tissue of the cyst wall (Fig 34). 
 
Figure 33: Photomicrograph of the atrophic cyst. (H&E, magnification x 20) 
 
 
Figure 34: Photomicrograph of the epithelial island in cyst wall. (H&E, 
magnification x100) 
 
 
 
 
 
64  
4.5 Comparison of silk suture and nylon suture 
 
Table 14: Evaluation of two kinds of sutures. 
 Nylon Suture 
Silk 
Suture Total 
Wound healing with 
intact or partial cyst 
formation 
Without 
contaminants 5 5 10 
With contaminants 6 1 7 
Wound healing without cyst formation 2 4 6 
Ingrowth of mouse epidermis with partial 
cyst formation 3 3 6 
Poor wound healing 3* 8 11 
Animal died before wound healing 2 1 3 
Total 21 22 43 
* Poor wound healing of implants in two mice was due to the wound being compromised by 
forcible restraint when the animals were administered with Gentamicin injection without 
anaesthesia in the beginning of the experiment. 
 
 
The number of poor wound healing cases which were stitched with silk sutures 
was nearly three times higher than that observed in those cases when nylon 
sutures were used. The ingrowth of murine epidermis was also more pronounced 
in the silk suture groups than in the nylon suture groups (Fig 35 C, D). Even 
though there were same numbers of cases without bacterial contamination in both 
suture groups, the inflammation around silk sutures was generally more severe 
than that around nylon sutures (Fig 36 C, D). A foreign body reaction and acute 
inflammatory infiltrate usually surrounded the silk sutures (Fig 37). 
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Figure 35: Photos of skin wounds. A) wound healing (nylon suture), B) wound 
healing (silk suture), C) epidermal ingrowth (nylon suture), D) serious 
epidermal ingrowth (silk suture), E) poor wound healing (nylon suture), 
F) poor wound healing (silk suture) 
 
 
A  B  
C  
E  F 
D 
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Figure 36: Photomicrograph of the sutures. (H&E, magnification x 100) 
A) Mild inflammation around nylon suture in the implant without 
contaminants.  
B) Mild inflammation around silk suture in the implant without 
contaminants.  
C) Inflammation around nylon suture in the implant with contaminants.  
D) Severe inflammation around silk suture in the implant with 
contaminants.  
 
 
A B 
C D 
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Figure 37: High-power photomicrograph of a foreign body reaction around a silk 
suture. Foreign body giant cells (arrows) were present. (H&E, magnification x 
200) 
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CHAPTER 5: DISCUSSION AND CONCLUSION 
5.1 Identification of the contaminants and evaluation of antibiotic cover 
 
 
5.1.1 Common pathogenic organisms 
In the present study, Enterobacter cloacae, Enterococcus faecalis, Klebsiella 
oxytoca, Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis 
were isolated from the neck regions of the nude mice before operation. These 
organisms are the normal commensals of healthy animals (ILAR, 1996). 
Staphylococus aureus and Streptococci were only carried by 3 mice. Coagulase 
negative staphylococci (CNS) were the most commonly isolated organisms 
(17.8%) before the implantation; they are considered potentially pathogenic in 
this model.  
 
After the implantation of the artificial cyst, CNS were still the most frequently 
isolated pathogenic organisms (58.1%), followed by Enterococcus faecalis 
(22.6%). This is in agreement with the recent data of the National Nosocomial 
Infection Survey (NNIS), in the USA, which CNS and Enterococci are ranked 
second and third most common cause of postoperative surgical site infection 
(CDC NNIS, 1997; Mangram et al, 1999).  
 
Over the last two decades, it has become apparent that CNS is the most significant 
pathogen in medical-device-related infections and in immunocompromised 
patients (Wieser & Busse, 2000). NNIS found that from 1980 to 1989, the 
incidence of CNS as a common cause of nosocomial bacteremias increased from 9 
to 27%. Hence, it has become the single most common cause of these infections 
(Archer & Climo, 1994). In another recent study (Edmiston, et al, 2005), CNS 
was recovered from 86% of air-samples isolated from the operating theater. CNS 
produced multiple infections, such as bacteremia, catheter-related infections, 
central nervous system shunt infections, endocarditis, urinary tract infection, 
surgical site infection and endophthalmitis (Huebner & Goldmann, 1999). Almost 
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all cases of bacteremia due to CNS were nosocomial in origin and are related to 
an indwelling foreign body.  
 
The past few years have witnessed increasing interest in enterococci which 
tolerate a wide variety of growth conditions, including temperatures of 10°C to 
45°C, and hypotonic, hypertonic, acidic, or alkaline environments (Huycke, 1998). 
Enterococci have become recognized as leading causes of nosocomial bacteremia, 
surgical wound infection, and urinary tract infection (CDC NNIS, 1997). 
 
5.1.2 Putative source of contaminants 
 
In this study, the athymic nude mice (MFI nu nu) that were used were 
immunodeficient animals, but not germ-free. It is believed that the contaminant 
organisms of these animals were acquired at the University of the Witwatersrand 
(Wits) Animal Unit (Johannesburg) and transmitted from animal to animal in 
same transport batch. The mice were transported from the Wits Animal Unit in 
Johannesburg to the laboratory on main campus of UWC in Cape Town, by road 
and air in a single sterilized air-filtered cage in batches of six. On arrival at the 
laboratory, the whole cage was transferred into an isolator. The animals were then 
accommodated into two separate cages in batches of 3 each. The floor of the cages 
was covered with a bedding of autoclaved wood shavings. The animals were fed 
ad-lib with normal sterilised water and autoclaved rodent breeder food. Up to this 
stage, there was no opportunity for the animals to have been in human contact in 
the laboratory before the implantation procedure. In support of our assumption 
that the animals were infected at Wits animal unit, bacteria species were isolated 
from the individual batches. Klebsiella pneumoniae was isolated in larger 
numbers from batches 4 and 5; Pseudomonas aeruginosa was isolated in larger 
numbers from batches 4, 5 and 9; and β-haemolytic streptococcus group A was 
isolated only from batch 8 and 9. 
 
It is believed that CNS which was isolated from the cyst after 9 weeks of growth, 
might have been introduced by the ventilated air of the substandard animal room. 
Microbiology of room air samples only isolated two bacterial colonies.  
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5.1.3 Inflammation and infection of the cysts 
 
The contamination, inflammation and infection control in this experiment was not 
deemed entirely satisfactory even though isolators were used and antibiotic cover 
was instituted. It was observed, in cases with good healing, that the inflammatory 
focus was located at the cyst wall closest to the mouse epidermis (Fig 25). In 
cases of poor wound healing, there was marked contamination and inflammation. 
This was noted in 6 mice which showed epidermal ingrowth, 11 mice presented 
with opened wound and 3 mice died as a result of euthanasia. The infections that 
resulted in poor wound healing could be surgical site infections (SSI). These are 
defined as infections involving only the skin or subcutaneous tissue at the incision 
sites. In a few mice, “Stitch abscess” also presented which is defined as minimal 
inflammation and discharge confined to the points of suture penetration 
(Mangram et al, 1999). In addition, mice in which the silk suture was used 
showed marked inflammatory reaction at the suture site. This inflammatory tissue 
response was thought to be elicited by the use of silk suture material (Moy et al, 
1991).  
 
In the last two decades, SSIs has remained a major cause of nosocomial 
(hospital-acquired) infections with increasing global rates. In epidemiologic 
studies, risk factors of SSIs were identified by multivariate analyses. These 
included patient or operation features, such as the patient’s age, nutritional status, 
altered immune response, etc. Operation factors included duration of operation, 
preoperative preparation, skin antisepsis, antimicrobial prophylaxis, foreign 
material in the surgical site, etc (Cruse, 1992; SHEA, 1992). The implantations of 
the cysts were preformed in a substandard animal room with no scrub suits or 
gowns worn by the operator. This is in direct contradiction to the SSI prevention 
measure suggested by the Hospital Infection Control Practices Advisory 
Committee, USA (Mangram et al, 1999). However, there is limited data 
describing the use of scrub suits or gowns in terms of SSI’s risk in general.  
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Although CNS can produce serious postoperative infection, especially in patients 
with implanted foreign material, there may be a tendency to attribute SSI’s to 
organisms that are merely skin-flora contaminants in culture specimens (Boyce et 
al, 1990). In the present study, the contraction of contaminants is possibly due to 
a lack of an efficient cover dressing after the implantation of the cyst. An ideal 
wound dressing should maintain a moist environment, enable gaseous exchange, 
and protect from secondary infection. The dressing should also be comfortable, 
and able to be removed without causing trauma (Dale, 1997). The ideal surgical 
dressing also aims to stimulate superficial epithelialisation when placed over a 
surgical incision wound. In so doing, it intends to protect underlying structures 
from contamination and infection (Wynne et al, 2004). Vapour-permeable, 
adhesive-coated dressings such as Opsite™ and Tegaderm™ are sterile, thin, 
vapour-permeable, hypoallergenic dressings that are sometimes used on surgical 
incisional wounds (Pudner, 2001). These dressings require care when being 
removed as their adhesive borders can cause possible tissue damage if their 
removal is not according to manufacturer’s recommendation. Opsite Post-Op™ 
dressing has a vapour-permeable film border which can be removed by gently 
stretching the material horizontally away from the wound (Thomas, 1996). 
 
 
5.1.4 Efficiency of antibiotic coverage 
In this study, Terramycin and Gentamicin were used as antibiotic cover for CNS. 
Terramycin was efficient in preventing Staphylococcus aureus infection, but did 
not produce the desired efficiency to CNS. There was no difference in the number 
of the cases with intact cysts, between the Terramycin/vitamin cocktail group and 
the control group. Gentamicin proved to be more efficient against Gram-negative 
contaminants than Terramycin. This was confirmed by the microbiological results 
in this study. The body weights of the mice in groups 1 and 3, in which Gentamicin 
injections were administered, increased to a lesser degree than that of the mice in 
groups 2 and 4, where Gentamicin injections were not administered. Despite their 
discomfort, subjecting the mice to twice daily injections is definitely advisable 
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than just adding an antibiotic cocktail in drink water. This is acceptable because 
the body weight of the mice continued to increase after the injections. 
 
The proportion of nosocomial CNS resistant to methicillin, oxacillin and nafcillin 
increased from 20 to 60% in the 1980’s in the United States. Most of these 
methicillin-resistant CNS were also resistant to multiple additional antimicrobial 
agents (Archer & Climo, 1994). When CNS isolates are resistant to commonly 
used antibiotics, the glycopeptide vancomycin has been considered to be the 
antibiotic of choice (Kloos & Bannerman, 1994). Vancomycin is recognized as 
one of the most potent anti-staphylococcal drugs available, especially to hospital 
acquired infections caused by antibiotic resistant strains. It is the drug-of-choice in 
the treatment of serious methicillin-resistant S. aureus infections (Chang et al, 
2003). It has been suggested by Shelburne, et al (2004) that by adding low 
concentrations of gentamicin to vancomycin, led to substantial synergistic 
bactericidal activity against methicillin-resistant Staphylococcus aureus. 
Vancomycin-Rifampin-Gentamicin is the standard treatment for deep S. 
epidermidis infection (Secasan, 2005). Combined treatment with 
vancomycin-gentamicin is also highly efficient in patients with endocarditis 
caused by penicillin-resistant Streptococcus sanguis (Martinez. et al, 1995). The 
combination of gentamicin plus vancomycin was the most effective regimen in 
the experimental endocarditis animal model (Righter, 1987). In the present study, 
the reports of antibiotics sensitivity testing on the isolated organisms showed that 
all strains of CNS were sensitive to vancomycin. The recent emergence of 
vancomycin intermediate S. aureus (VISA) and vancomycin-resistant S. 
haemolyticus emphasizes the importance of using this agent selectively and 
appropriately (Huebner & Goldmann, 1999). Another glycopeptide, Teicoplanin 
has been used with some success, as an alternative to vancomycin against some 
vancomycin-resistant strains of Enterococci, and in the treatment of moderate and 
severe infections by CNS (Kloos & Bannerman, 1994). 
 
The past two decades have witnessed the rapid emergence of multiple-drug 
resistant (MDR) Enterococci (CDC NNIS, 1997). The therapeutic challenge of 
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MDR Enterococci - those strains with significant resistance to two or more 
antibiotics, often including, vancomycin - has brought their role as important 
nosocomial pathogens into sharper focus. Enterococci are intrinsically resistant to 
many antibiotics. Unlike acquired resistance and virulence traits, intrinsic 
resistance is based in chromosomal genes, which typically are nontransferrable. 
Penicillin, ampicillin, piperacillin, imipenem, and vancomycin are among the few 
antibiotics that show consistent inhibitory, but not bactericidal, activity against E. 
faecalis (Huycke, 1998). MDR Enterococci that had lost susceptibility to 
vancomycin were reported in Europe (Leclercq et al, 1988) and the United States 
(Sahm et al, 1988).  
 
 
5.2 Wound dehiscence and comparison of two non-absorbable sutures  
In this study, the non-absorbable suture materials, silk 5-0 and nylon 5-0, were 
used as a substitute for absorbable sutures which produced a foreign body reaction 
and acute inflammation noted by Thompson (2002). Silk suture was booked in 
these experiments as it was thought be less irritative near the wound edges and 
easier to apply than nylon sutures. However, the wounds of eight mice (20%), 
whose skin was stitched with silk sutures, showed wound dehiscence or poor 
wound healing. Twice as many mice presented with the features of dehiscence 
and poor healing than those mice stitched with nylon sutures. Marked 
inflammation was also noted around silk sutures of the artificial cyst. The 
infection risk associated with silk sutures was significantly higher than that with 
nylon sutures. 
 
Silk used for suturing has the lowest tensile strength of any material tested, and 
elicits a considerable tissue reaction. Adamsons and Kahan (1970) demonstrated 
that rabbit skin wounds closed with a continuous 4-0 silk suture, regained only 
40% of the strength of normal tissue 120 days after wound initiation. Van Winkle 
and associates (1975) noted that skin wounds approximated by different 
percutaneous sutures developed 70% of their normal strength by 120 days in the 
dogs. Superior tensile strength and knot security not only minimizes the risk of 
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suture line disruption, but also potentially reduces the amount of foreign material 
left in the wound (Moy et al, 1991). 
 
Postlethwait and colleagues (1975) found that multifilamentous natural fibers, 
such as catgut and silk, cause the most intense inflammatory reactions, whereas 
monofilamentous synthetic materials, such as nylon and polypropylene, generate 
less reaction. Silk also has a high degree of capillarity because of its braiding and 
should not be used in wounds where there is increased potential for infection. In 
skin surgery, silk is used around the eyelids and lips, where it lies flat, causes 
minimal irritation and has a low incidence of infection (Moy et al, 1991). 
 
In a study completed by Chu et al (1987), it was found that a new type of braided 
nylon thread with a silver compound coating exhibited moderate to good 
bactericidal property against the following seven bacterial species: S. aureus, E. 
coli, P. aeruginosa, K. pneumoniae, S. dysenteriae, S. maruslene, and P. 
mirabilis. 
 
It was well documented that the diminished tensile strength of wounded skin 
compared to the normal skin, correlated with the appearance of narrower collagen 
fibres present in the wound as opposed to normal collagen (Lin & Long, 2005). 
The continuous production of keratin by the cyst epithelium may not only lead to 
the increased intraluminal mechanical pressure, but also produce pressure to the 
wounded skin due to the increase in size of the cyst. Wound dehiscence and 
resulting necrosis was observed in 4 mice after 6 weeks of cyst growth.  
 
 
 
 
 
 
 
 
75  
 
5.3 Evaluation of the animal model 
 
5.3.1 Observation of animal housekeeping 
In general the nude mice survived the experiments quite well and no major 
problems were encountered in housekeeping them during this study. Nevertheless, 
ten mice were lost before the implantation and 6 mice were lost after the 
implantation procedure. Low ambient temperature during airfreight or in the 
animal room due to a power shutdown accident could have possibly resulted in 
the death of 6 mice in batch 2. An overdose of anaesthetic was another reason of 
the death of 2 mice in batch 1. The loss of three post-implantation mice could be 
attributed to the toxicity of peracetic acid, a strong disinfectant for the sterilisation 
of the port of the isolators. Another 3 mice with implants in the control group 
were euthanised after 3 weeks as severe inflammation around the opened wounds, 
persistent anorexia, and inability or impairment to move was observed.  
 
Aggression (climbing the cage cover and jumping), repetitive roaming behaviour, 
nervousness and handling difficulties were observed with some of the mice during 
this study. These symptoms are defined as the behavioural patterns of ‘isolation 
stresses’ which were present in the mice as they were accommodated individually 
in single cage (Balcombe, 2006). Other physiological symptoms including lower 
immunocompetence, higher tumour incidence, gastric ulcerations, 
hyper-sensitivity to toxin and increased pathology are also present in 
single-housed mice (Van Loo et al, 2003). However, in this study, the death of 
three mice was associated with the toxicity of peracetic acid. 
 
Preferences for hiding shelters and nesting materials have been repeatedly 
demonstrated in mice. Mice are strongly motivated to build nests not only for 
breeding, but also for temperature and light regulation. In this study, the mice 
often made their nest in the shadow of the food hopper and/or drinking bottle as 
noted in the previous study (Van Loo, et al, 2004; Balcombe, 2006). The 
implantation sites at the neck region of some of the mice were scratched by the 
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steel food hopper; this could be due to the small size of standard cages (14 cm in 
width, 30 cm in length, and 15 cm in depth). This could have possibly aggravated 
the dehiscence of the wound stitched with silk sutures. 
 
 
5.3.2 Shortcomings of the isolator 
In all likelihood, Staphylococci were transmitted between the mice within the 
isolators after implantations. An accident of Glycerol flowing back from the 
liquid filter into the isolator could have been the reason that nine of 14 mice 
showed Staphylococcus species. Two mice showed bacteria isolates of S. aureus 
and 7 mice showed isolates of CNS from inside the cysts at harvest. Eight of 10 
mice that were maintained in another isolator, also showed isolates of 
Staphylococcus species at harvest. These included 1 mouse from which S. aureus 
was isolated and 7 mice from which CNS was isolated. In these 17 mice, S. 
aureus was isolated only from one mouse and CNS was isolated form another 
mouse before implantation.  
 
Microbiological reports on the random samples of air from inside the isolator 
showed no bacterial growth. It should be noted that the microbiological sampling 
of air was not optimal due to a lack of an effective sampling protocol and a 
quantifiable measure of success of the decontamination for monitoring of the 
isolators in this study.  
 
The isolator filters were dust filters constructed from three layers of fiberglass 
filter material. The filters were then wrapped in paper bags and sterilized by an 
autoclave. A plastic shield carrying a hose adaptor was placed around the filter 
and sealed by 3M® stretchable tape. It is possible that the plastic shield might not 
have provided an adequate seal and hence prevention of microbiological 
contamination could have been compromised. 
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The type of filter used also makes a difference in the degree of decontamination 
of isolators. The high efficiency particulate air (HEPA) filters which have an 
efficiency rate of 99.97% are being used in various high technology industries, 
such as aerospace, pharmaceutical processing, hospitals, healthcare, nuclear fuels, 
nuclear power, and electronic microcircuitry (computer chips) (DOE, 1997). 
These filters have the ability of removing particles the size of 0.3 microns from 
the air. These filters filters are critical in the prevention of the spread of airborne 
bacterial and viral organisms. When the HEPA filters are used in a medical 
environment, the filtration systems also incorporate high-energy ultra-violet light 
units which kill off the live bacteria and viruses that might be trapped by the filter 
media. Some of the best-rated HEPA units have an efficiency rating of 99.995%, 
which assures a very high level of protection against transmission of the airborne 
disease (Zajac, 2006).  
 
 
5.4 Comparison of the cyst model with the Thompson studies 
 
In this study, the non-keratinised stratified squamous epithelial lining of the 
implanted cysts was microscopically similar to that of the vaginal mucosa from 
which the cysts were constructed. It is well documented that the cyst lining 
forms at 6 weeks after the implantation, but the sutured edges of the cysts healed 
completely at 9 weeks (Thompson et al, 1996). There was not a remarkable 
difference in the number of the cell layers between the 9 weeks old cysts and the 
control vaginal epithelium. However, there was a statistical difference in the 
number of cell layers between the 10 weeks old cysts and the donor vaginal 
epithelium, as noted in the studies by Thompson and his colleagues (1996, 
2001b, 2002). In some individual cysts which contained larger amounts keratin, 
the cyst lining was thinner than that of the donor vaginal epithelium. This could 
possibly be attributed to an increased intraluminal mechanical pressure on the 
cyst epithelium due to the continuous production of keratin (Fig 18A). This 
increased pressure may also result in the lack of rete pegs at the epithelium/ 
connective tissue junction. The feature of the thinner cyst lining could also 
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possible be due to the lack of re-establishment of the new blood supply which 
was as representative of the nutritional capacity of the cyst model. Marked new 
blood supply resulted in the thicken regions of the epithelial layer of the 
implanted artificial cyst. 
 
The goals of the present study were to identify the common pathogens and factors 
that could adversely affect the establishment and maintenance of the mucosal 
cysts and to offer significant improvements in infection control of the cyst model 
constructed from human vaginal mucosa in athymic nude mice, which was 
established by Thompson and co-workers (1996, 2001b, 2002). However, the 
successful rate of this study was not better than that of Thompson studies and the 
contaminants were isolated from 75% mice after 9 weeks. It could be attributed to 
the shortcomings of the isolators in the substandard animal housing room. 
   
 
5.5 Toxicity of peracetic acid (PAA) 
 
Toxicity of PAA is high via oral administration to guinea pigs, and moderate via 
oral and dermal routes for rats and rabbits. Skin, Oral and Eye Irritation Data: 
skin-rabbit LD50 1410 mg/kg; oral-rat LD50 1540mg/kg, eye-rabbit 1 mg SEV 
(OMRI, 2000a, UPSC, 2000). It is caustic and corrosive at concentrations >10% 
and irritative concentrations below 2%. The irritant of the skin, eyes, mucous 
membranes, and respiratory tract produces the burns, inhalation and ingestion 
injuries.   
 
In this study, PAA proved to be toxic by inhalation and eye irritation, but was 
most probably also absorbed through the skin. One mouse that was transferred 
from the laminar air-flow unit to the isolator via the port sterilized with PAA, 
became blind after being present inside the port for 2 minutes. The animal 
subsequently died 5 days later. The death of two other mice could also be 
attributed to the possible leakage of PAA from the port cover due to their 
frequent proximity to the port. These mice presented with persistent anorexia and 
lethargy.  
 
 
 
 
79  
 
For the present study, PAA was acquired as acetic acid (100%) and hydrogen 
peroxide (30%). These two chemicals were mixed 10 days prior to use. It is also 
believed that there could have been an error in the strength of PAA mixed in our 
laboratory. Enviro Tech Chemical Services, Inc., USA (2006) described the 
process of determining hydrogen peroxide and peracetic acid content of a PAA 
sample at equilibrium as an extremely difficult process. 
 
A new formulation has recently been developed: Perasafe®. This consists of a fine 
powder which contains a combination of peroxygen compounds, organic acids 
and stabilizers. This formulation liberates peracetate ions equivalent to 0.26% 
PAA into the medium. It can be manipulated easily using with gloves and there is 
no release of toxic residues (Vizcaino-Alcaide, et al, 2003). Health and Hygiene 
Inc. (2004) have also released another low irritative disinfectant, F10 SC 
Veterinary Disinfectant. This has been introduced to use at animal facilities in 
recent years.  
 
 
5.6 Other problems encountered in this study 
Ulceration of cyst linings without infection: This feature was observed in 8 mice 
in which there was partial cyst formation (Fig 22A). This could be attributed to 
the destruction of the vaginal epithelium by forceps during the vaginal 
hysterectomies or during manipulation and manufacture of the artificial cyst. 
 
Atrophic cysts: This feature could possibly have been due to pressure exerted by 
the silastic tube on the vaginal mucosa, which were relatively small in size, with 
a resultant decreased blood flow and possibly ischemia. 
 
Intracystic fibrosis: Unusual fibrosed human connective tissue was present in a 
single cyst cavity; the cyst surrounded by granulation tissue. This phenomenon 
could possibly have resulted from reversal of the vaginal epithelium during the 
construction of the artificial cyst; hence the vaginal epithelium faced the murine 
connective tissue directly. 
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Epithelial islands in connective tissue  This phenomenon is believed to be due 
to the vaginal epithelium of the artificial cyst at the edges of the sutures being 
implanted into the connective tissue and is unlikely to affect the cyst growth. 
 
Fibrosis at junction of the host connective tissue and implanted connective 
tissue: It was observed that marked fibrosis developed at the junction of mouse 
connective tissue and implanted human vaginal connective tissues that of three 
specimens were not treated with EDTA prior to cyst construction and 
implantation due to time constraint. The resultant fibrosis is a normal defence 
mechanism of the mouse and is not likely to affect the cyst lining. 
 
 
5.7 Conclusion 
We have provided histological evidence that the structure of the epithelium of the 
implanted cyst retained the main characteristics of the vaginal epithelium from 
which it was constructed. We have also reaffirmed that this experimental cyst 
model is potentially suitable as an in vivo biotest model for studies involving the 
oral mucosa. In this study, we showed that the coagulase negative staphylococci 
were the most common pathogenic microorganisms and caused necrosis of the 
cyst epithelium. Severe inflammation was seen around the suture area of the skin 
wounds due to the contamination. Gentamicin proved to be more efficient against 
Gram-negative contaminants than Terramycin. It was also found that the nylon 
suture was the appropriate non-absorbable suture in minimizing the infection 
around the experimental cysts. An alternative low irritative disinfectant should be 
chosen and the prevention of microbiological contamination was compromised 
when the isolators were used in the substandard animal room. 
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CHAPTER 6: RECOMMENDATIONS 
Further recommendation for future research: 
 
1) Substandard housing condition of the isolators must be avoided at all times; 
2) An effective protocol should be designed to monitor the isolators;  
3) The high efficiency particulate air (HEPA) filter could be a suitable filter for 
sterilizing the air of the isolator; 
4) Peracetic acid should be used at concentrations blow 2%; and alternative low 
irritative disinfectant should rather be used; 
5) Vancomycin plus Gentamicin could be applied to minimize the infection of 
coagulase negative staphylococci; 
6) Opsite dressing could be used post-operative period to limit the leakage of the 
wound. 
 
 
This model could be used as a in vivo biotest model to perform studies on: 
 
1) The combined chemical and viral carcinogenicity of the oral and upper 
airway mucosa; of particular interest are:  
a) the absorption and distribution characteristics of these carcinogens in the 
sub-epithelial tissues of the cyst,  
b) the proliferative and (pre-) malignant epithelial changes in response to 
these viruses and carcinogens,  
c) the molecular biological mechanisms underling these changes. 
2) The pathogenesis of various other mucosal conditions, in particular of 
inflammatory, viral and immunopathological nature. 
3) The molecular genetics, proteonomics and growth factors in a cyst model. 
4) The receptor of virus on the oral and vaginal mucosa 
5) The local and systemic effects of drugs and immunisations on diseases that 
involve oral mucosa.    
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APPENDIX I: Preparation of peracetic acid (PAA) 
 
? Acetic Acid (100%) (CH3COOH, 1L=1.05Kg) (Merck® [Pty] Ltd, 
Wadeville, SA. Licence from Merck, German) 
 
? Perhydrol (30%) (H2O2, 1L=1Kg) (Merck® [Pty] Ltd, Wadeville, SA. 
Licence from Merck, German) 
 
Recipe 
? 450ml Acet acid 
? 100ml Perhydrol 
? Prepared 10 days prior to use 
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APPENDIX II: Terramycin/ Vitamin cocktail 
 
? Terramycin (5% oxytetracyclin) powder (Highveld Biological [Pty] Ltd, 
Sandringham, SA) 
 
? Vitamins MEM (100x) (Cat 216, Highveld Biological [Pty] Ltd, 
Sandringham, SA)  
 
 
Recipe  
Given after implantation 
? 1g Terramycin powder in 100ml sterilized water 
? 1ml Vitamin MEM / 100ml drink water     
? 50ml per mouse every third day- freshle prepared,  
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APPENDIX III: Animal husbandry information form 
Animal no: 
Ref no: 
Date of arrival 
Date of implantation: 
  
Date Weight Food and 
water 
Injection Health Room 
temperature 
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APPENDIX IV  
Participant information leaflet and consent form 
TITLE OF THE RESEARCH PROJECT: 
“Contamination, infection and inflammation control in an experimental mucosal cyst model 
using athymic nude mice” 
 
REFERENCE NUMBER: N05/04/061 
PRINICIPAL INVESTIGATORS: Prof J Hille, Dr M Wang 
ADDRESS: 
UWC Academic Oral Health Centre, Tygerberg  
Anatomical Pathology Laboratories, Tygerberg Hospital 10th Floor, Tygerberg Hospital 
Private Bag X1, 7505 Tygerberg,  
Cape Town, South Africa 
CONTACT NUMBER: 021-9386159 / 082-5560703 
 
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the 
study staff or doctor any questions about any part of this project that you do not fully 
understand. It is very important that you are fully satisfied that you clearly understand what 
this research entails and how you could be involved. Also, your participation is entirely 
voluntary and you are free to decline to participate. If you say no, this will not affect you 
negatively in any way whatsoever. You are also free to withdraw from the study at any point, 
even if you do agree to take part. 
This study has been approved by the Committee for Human Research at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice 
and the Medical Research Council (MRC) Ethical Guidelines for Research. 
What is this research study all about? 
? There is a need for a stable experimental model, which offers a closed environment 
similar to the oral cavity and which allows for controlled studies on the mucosal 
absorption mechanisms and local reaction patterns to introduced agents such as 
carcinogens, viruses, drugs and vaccines. 
? Human vaginal tissue has been used as a substitute for oral mucosa in in-vitro and 
in-vivo experimental studies. Our implantation cyst model which is constructed from 
human vaginal mucosa and grown in athymic nude mice could be used as an in-vivo 
biotest system to study oral diseases. This project seeks to identify the contaminant 
microorganisms and to successfully prevent the risk of infection and failure of this 
cyst model by applying various antibiotic coverage modalities and eliminating other 
possible contaminants or irritating factors.  
Why have you been invited to participate? 
? As you are about to undergo a vaginal hysterectomy or other corrective surgical 
gynaecological procedure, there very likely will be some excess vaginal tissue 
available which otherwise will be sent to the pathology laboratory (by law) with the 
uterus for routine investigations.  
? We are asking you for permission to examine this immediately after the operation 
and, if it looks normal, separate your healthy vaginal tissue from the main specimen 
before it is being stored in a fixative. The vaginal tissue will be specially treated and 
prepared in the laboratory and inserted into nude mice to grow an experimental cyst 
from it. Any tissues that do not appear normal will be examined with the uterus in 
the histopathology laboratory and not used for the experiment. 
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What will your responsibilities be? 
Your responsibilities as a participant are solely passive and consist only of agreeing 
to donate the excess tissues from your hysterectomy specimens for implantation into 
experimental nude mice. 
Will you benefit from taking part in this research? 
You as a participant will not directly benefit from this project.  
If successful, research using this in-vivo biotest model may lead to establishment of 
improved medical services. 
Can you sustain injury as result of your taking part in this research study? 
Are there any other risks involved in participating in this study?  
No, absolutely not. You will bear no more risk other than that associated with the 
routine hysterectomy procedure. We would like to reassure you that under no 
circumstances any extra tissue will be harvested other than that is included in routine 
hysterectomy procedures. 
Who will have access to your medical records? 
 Only the investigators will keep a confidential laboratory logbook in which your 
absolute minimum data will be recorded e.g. the hospital number, age and surgical 
indication for the hysterectomy. All information collected will be treated as 
confidential, and it will for instance be included in a thesis, a publication in a 
professional journal, etc, without disclosing your identity.   
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be paid to take part in the study.  
There will be no costs involved for you, if your tissue is used in the experiment. 
The hysterectomy procedure and the routine pathology examination are not part of 
the research project. 
Is there any thing else that you should know or do? 
You can contact Prof Jos Hille at tel 021-938 6159 if you have any further queries or 
encounter any problems. 
You can contact the Committee for Human Research at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by your study doctor. 
You will receive a copy of this information and consent form for your own records. 
 
By signing below, I………………………….. agree to take part in  a research 
study  entitled:- “Contamination, infection and inflammation control in an 
experimental mucosal cyst model using athymic nude mice” 
 
 
 
I declare that: 
• I have read or had read to me this information and consent form and it is written in a 
language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been adequately 
answered. 
• I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
• I may choose to leave the study at any time and will not be penalisd or prejudiced in 
any way. 
• I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
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Signed at (place)…………………………..on (date) ……………………………….. 2006 
 
 
 
 
…………………………..                               ……………………… 
Signature of Participant                                  Signature of Witness.  
 
 
Declaration by Investigator 
 
I  (name )  …………………………………………………declare that:- 
 
• I explained the information in this document to ………………………………….. 
• I encouraged her to ask questions and took adequate time to answer them. 
• I am satisfied that she adequately understands all aspects of the research, as discussed 
above 
• I did/did not use a translator. (If a translator is used then the translator must sign the 
declaration below. 
 
Signed at (place)…………………………..on (date) ……………………………….. 2006 
 
 
…………………………..                                  ……………………… 
Signature of Investigator                                    Signature of Witness.  
 
 
Declaration by Translator   
 
I (name )  …………………………………………………declare that:- 
 
• I assisted the investigator (name)…………………………. to explain the information 
in this document to (name of participant)…………………………….. using the 
language medium of Afrikaans/Xhosa. 
• We encouraged her to ask questions and took adequate time to answer them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 
 
. 
Signed at (place)…………………………..on (date) ……………………………….. 2006 
 
 
…………………………..                                 ……………………… 
Signature of Translator.                                   Signature of Witness.  
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APPENDIX V: Transport Medium 
 
? Dulbecco’s Minimum Essential Medium (DMEM) with 4.5g/l glucose 
without L-glutamine (Cat no L02-cm, Highveld Biological [Pty] Ltd, 
Sandringham, SA) 
 
? 10% Fetal calf serum (Cat no 306, Highveld Biological [Pty] Ltd, 
Sandringham, SA) 
 
? Antibiotic-Antimycotic mixture consisting of streptomycin (10 000 
μg/ml), penicillin (10 000 units/ml), and Fongizone (25 μg/ml) (Cat no 
228-cm, Highveld Biological [Pty] Ltd, Sandringham, SA ), 
 
 
Recipe 
 
? 900ml DMEM 
? 100ml Fetal calf serum 
? 10ml Antibiotic-Antimycotic 
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APPENDIX VI: EDTA 
? Dulbecco’s phosphate Buffered Saline (DPBS) with, with (Highveld 
Biological [Pty] Ltd, Sandringham, SA) 
 
? EDTA (Versene®) 0.1% (in Ca++ and Mg++ free PBS) mix 1:1 with trypsin 
(0.25%) (Highveld Biological [Pty] Ltd, Sandringham, SA) 
 
 
Recipe: 3mM EDTA (100ml) 
? 37.2ml 0.1%EDTA 
? 62.8ml DPBS 
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APPENDIX VII  
1. Evaluation form of donor vaginal tissue  
Vaginal tissue number: 
 
2. Evaluation form of cyst wall 
Tygerberg Reg No: 
Animal number:  
Ref number: 
Harvest Date: 
 
 Maximum num of cell layers Minimum num of cell layers Inflammation +/- 
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
11    
12    
AV    
SD    
 
Cyst 
formation 
or Cyst 
necrosis 
Maximum 
num of 
cell layers 
Minimum 
num of 
cell layers 
Inflammation 
under 
basement 
+/- 
Contaminant 
G stain +/- 
Fibrosis in 
connective 
tissue  
+/- 
Blood 
supply 
+/- 
1 
 
  
    
2   
3   
4   
5   
6   
7   
8   
9   
10   
11   
12   
AV   
SD   
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APPENDIX VIII: Anaesthetics 
 
(1) ISOFOR® (100ml) (Safe Line Pharmaceuticals [Pty] Ltd, SA) 
 
(2) Anaket-V® (10ml) (Ketamine 100mg/ml) (Bayer [Pty] Ltd, SA) 
 
(3) Domitor® (10ml) (Medetomidine hydrochloride 1.0mg/ml) (Novartis South 
Africa [Pty] Ltd) 
 
 
Dilution protocol 
Take 0.1ml (2) and add 0.9ml saline (Ketamine = 10mg/ml) 
Take 0.1ml (3) and add 0.9ml saline (Medetomidine = 0.1 mg/ml) 
 
Administration 
Inject subcutaneously into mouse 
0.05-0.07ml (4) + 0.09-0.13ml (5) per mouse at the dose of Ketamine [25mg/kg] 
+ Medetomidine [0.5mg/kg] 
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APPENDIX IX: Other antibiotics and disinfectants 
 
? Penicillin-G solution (10,000μ/ml) (Cat no 214-cm, Highveld Biological 
[Pty] Ltd, Sandringham, SA) 
 
? Gentamicin solution (1.32mg/ml) (Cat no 208-cm, Highveld Biological 
[Pty] Ltd, Sandringham, SA) 
 
? Povidone Iodene (Betadine®) (Kenndon Medical Supplies [TVL] [Pty] 
Ltd, SA) 
 
? Biocide® D Extra-30gm (General Medical Supplies, SA) 
 
? Virkon® (Adcock Ingram Critical Care [Pty] Ltd, SA) 
 
 
 
 
 
 
